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Abstract
The effects of the natural antioxidant vitamin E and 
synthetic antioxidant ethoxyquin on the ageing process were 
studied in rats from 21 to 702 days after birth. Two dose 
levels of vitamin E, 0.05$ and 0.5$ 3 and ethoxyquin 0.5$ 9 
were used in the diet. In the long term study, the body weight 
gain of animals receiving diets containing both 0 .05$ and
0.5$ vitamin E were greater than those of either pair-fed or 
ad~libitum fed controls and this suggests that the control diet 
was suboptimal with respect to its vitamin E conteit although 
the symptoms of vitamin E deficiency were not present. Early 
reduction in body weight gain in the 0 .5$ ethoxyquin-treated 
group was due to impaired palatability rather than impaired 
food utilisation because a similar growth rate was seen in the 
pair-fed controls. Later, however, the fall in the food intake 
and body weight correlated with the occurence of kidney damage. 
The liver and kidney weight of ethoxyquin-treated animals were 
significantly higher than in pair-fed controls. The kidney of 
the ethoxyquin-treated animals in the long term study showed 
chronic nephritis. In the short term study of two months, 0.5$ 
ethoxyquin in the diet did not show nephrotoxicity. No 
abnormalities were seen in the kidneys of animals receiving 
vitamin E in the diet.
The histology of bones of rats fed ethoxyquin for a long 
time suggested less deposition of calcium. In the short 
term study the humerus of ethoxyquin-fed rats contained a 
significantly lower level of calcium than in pair-fed controls 
and the bone weight was also significantly lower.
In the long term study of antioxidants, both 0.5$ vitamin
E and ethoxyquin in the diet caused a significant reduction
in PCV and a significant increase in the circulating reticulo­
cytes. Ethoxyquin also significantly increased the clotting 
time. In the short term study, animals receiving the diets 
containing 0.05$ vitamin E and 0 . %  ethoxyquin contained 
significantly more reticulocytes than pair-fed controls.
The clotting time was higher in antioxidant-treated animals, 
but the difference only reached statistical significance in 
the case of the 0.5$ vitamin E treated animals.
The accumulation of lipofuscin pigment in the brain of 
rats in the long term study showed a significantly lower 
intensity of fluorescence in animals that received both 0 .5$ 
vitamin E and ethoxyquin in the diet, in spite of the fact
IJ4 . .
that the entry of C ethoxyquin into the brain seemed to be 
small.
The possible relevance of this work to longevity and the 
ageing process is discussed.
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CHAPTER I
Introduction to ageing
Mortality rate in the elderly increases rapidly with advancing age 
for various reasons and few survive beyond 100 years, so that this may 
be considered the maximum life span of the human species. Overall life 
expectancy at birth has been rising gradually due to better medical 
care and public health facilities, so that today in the developed 
countries it is about 70 years. Degradative changes associated with 
ageing, culminating in the signs and symptons of degenerative disease, 
may be due to many reactions in the living system and these may be 
considered at all levels of organisation.
In spite of all the advances in medical knowledge the life expectancy 
at 45 years of age has only increased by 3 or 4 years in the last century. 
Furthermore, it has been estimated that if the three leading causes of 
death in Britain and U.S.A. (cardiovascular disease, cerebrovascular, 
disease, cancer) in this age-group were completely eradicated it would 
increase the overall life expectancy by only 5 ~ 7 years, and the life 
expectancy at the age of 65 by only 1.5 - 2.0 years (Comfort, 1965)•'
It is probably better to try to add to the quality of life by 
maintaing youthful vigour than to prolong an invalid or semi-invalid 
life beyond 70 years.
The phenomenon of ageing and death presents a biological problem of 
the greatest interest and importance (Strehler, 1967). The important 
question is whether ageing is an inherent feature of all cells and 
organisms. If it is, then a long life must be regarded as the mere 
postponement of inevitable death; if it is not, then a limited life 
span must be beneficial to the species. Most protozoans and many
lower metazoans fail to show ageing because of a continuous replacement 
regimen and so they have ’indeterminate1 life span (Strehler, 1962).
In the past, ageing has been regarded as an inevitable process 
which involves a gradual decline in capacities and “ultimately, death, 
and that nothing can be done about it. In recent years, with our increased 
knowledge of biology, biochemistry and physiology, this assumption of the 
inevitability of changes with age is not necessarily correct. As 
Comfort (1966, 1968) has pointed out, the key to the problem of increasing 
longevity is an understanding of the underlying mechanisms of the ageing 
process. Once these mechanisms have been fully explained, research can 
be directed to develop specific agents to decelerate, or even prevent 
senescence. Research on control of ageing has been hampered by failure 
to identify the cause or causes of the ageing process itself. The more 
we learn of the process of ageing the more complex it becomes. There."is 
also a lack of sound experimental data in support of any one theory of 
ageing, and it is difficult to distinguish between causes and effects,
i.e. between etiologic factors and the study of symptoms.
Theories of Ageing
There are many theories of ageing.
(a) Molecular basis of ageing
According to this theory, ageing is the result of cumulative 
molecular errors at various stages in a replicative process, involving 
DNA, RNA and protein synthesis (Medvedev, 1967).
It has been assumed that most of these changes are determined 
by specific genes and they control the rate of ageing and the life-
span of different species. It has been further hypothesised that 
it is the mutation of regulatory genes at the DNA level which 
contributes most to mutational alteration as a whole. The mutation 
of regulatory material is multiple in its consequences and its 
results far more severe than those of the mutation of single structural 
genes. . '
(b) Mutation Theory
This postulates that ageing occurs when cells cease to function 
or when their function is impaired because of the gradual accumulation 
of mutations in the prime genetic material. This could result in the 
failure of correct synthesis of necessary protein.
Eventually, a significant percentage of the body’s somatic cells 
function poorly (Strehler, 1962).
Some evidence supporting the mutation theory comes from experiments 
of Curtis (1966) showing that irradiated animals die sooner than control 
animals $nd they have the appearance of aged animals while still 
chronologically quite young. In many of the animals subjected to 
radiation, there was a premature onset of a number of diseases,and of 
cellular and biochemical changes characteristic of senescence. There 
appeared to be decreased resistance to stress which normally accompanies 
senescence.
(c) Cross-linking Theory
This theory supposes that the binding of two or mor large molecules 
such as proteins and nucleic acids by cross-linking gradually immobilises 
such macromolecules and cell function is impaired. Many macromolecules 
are sensitive to cross-linking, particularly DNA. In older animals DNA 
is less sensitive to thermal denaturation, it becomes, more stable,
(Von Hahn, 1963). The increased stability is related to binding 
of histones to DNA.
The increased rigidity of DNA may seriously impair code .transfer 
to messenger RNA, resulting in the synthesis of nonsense protein 
(Von Hahn & Verzar, 1963).
There are characteristic changes in collagen with age, Yerzar 
(i960) has suggested there is a decrease in solubility in yitro,
Evaritt et al (1968) has reported an increase in the breaking time 
of collagen fibres from the tail of rats. Further, it has been 
shown that collagen of older animals is digested enzymatically more 
slowly than that ot younger ones.
(d) Immunologic Theory
This theory suggests that mutated cells would stimulate immunologic 
reactions within the organism, and these immunologic reactions would 
degrade and eventually destroy the organism. Certain immunologic 
parameters change significantly with age, for example, the rise in serum 
gamma-globulins with advancing age in man. Renal lysozyme, which usually 
increases after immunisation and transplantation, also increases with, 
age in mice and certain strains of hamsters. Old human subjects show 
positive ^ reactions to anti-immune factors, as for example rheumatoid, 
antithyroid, etc (Walford, 1967 a, b). The weak point of this theory 
is that if anti-immune disease is a major factor in senescence, women, 
who are more subject to anti-immune disease than men, should have a 
shorter life span, but it is-well-known that women outlive men,
(Welch, 1967).
(e) Free radical theory
A free radical is a chemical species that has a lone unpaired 
electron in an outer orbital. Free radicals can be produced from many 
diverse compounds by physical means, such as irradiation with X-’-rays 
or ultra-violet light, or by chemicals known as initiators. The 
production of free radicals, a reaction known as 'initiation1, results 
in a marked change in the physico-chemical properties, the resultant 
free radicals usually being extremely reactive. Free radicals may 
undergo 'propagation' reactions, i.e.„chain reactions in which further 
radicals are generated and such chain reactions may ultimately be 
terminated by the combination of two free radicals to,produce a 
covalent bond. Such free radical reactions can take place readily 
in aqueous systems in the presence of oxygen and certain transition 
metal ions, conditions which are found in tiring tissue. Typical 
free radical reactions are shown below (Swern, 1961).
Initiation
Propagation
Termination
Copper or iron are catalysts for the initiation reaction and the 
quantity of RH - any organic compound - converted to other organic 
compounds depends on the number of times the propagation steps are 
repeated, that is, on the chain length of the reaction.
These free radicals, especially peroxy radicals, RO* , HO* , have
RH + 0o CU++ or Fe++. R* + HO '
R- +02 — ---— >R02*
ROg* + RH — -------  R« + ROOH
R* + R- — ------- -— > R : R
been implicated in a variety of endogenous reactions that are 
injurious to the cell. Since the endoplasmic reticular membranes 
are rich in lipid and bathed in an oxygen-rich cell sap* it may 
be expected that the propagation step •would readily be repeated..
It is well-known that incubation of liver, brain or kidney 
microsomes in buffer at approximately neutral pH produces lipid 
peroxides with formation of malonaldehyde and uptake of oxygen 
(Slater, 1972).
Antioxidants are capable of reacting with free radicals in a 
termination reaction without the further propagation or perpetuation 
of free radical reactions and not as radical reaction inhibitors.
In the inhibition of lipid peroxidation by an antioxidant (AH^) it 
is generally suggested that the peroxy-free radical is destroyed 
as shown below (Slater, 1972).
R- 0- 0* + AH2 ---:------ R- 00H + AH«
2AH* --- ;--- — -- > AH2 + A
R00* + AH* ---:-----^ R00H + A
Among the synthetic antioxidants are compounds such as butylated 
hydroxyanisole (BHA), butylated hydroxytoluene (BHT), ethoxyquin, and 
prophyl gallate.
Among the naturally occurring antioxidants are the tocopherols, 
ascorbic acid, gallic acid and nordihydroguaiaretic acid (WDGA).
Harman (1972) has shown that the mitochondria is one of the 
largest single sources of free radical production. In the complicated
reactions of the electron transport chain, electrons are passed 
from NADH and FADH^ via five different cytochromes to cytochrome 
oxidase. At this point molecular oxygen is reduced to water. In 
these reactions free radicals are transitorily produced as a result 
of oxidation-reduction reactions. Free radicals could react with 
the 'c = c of unsaturated fatty acids within membranes thus
/ N
causing lipid peroxidation which would result in decreased membrane 
integrity. If lysosomal membranes were involved, the released enzymes 
could cause hydrolytic destruction of cell constituents. This is one 
of the ways therapeutic radiation exerts its effects. Radiation reaching 
the aqueous cytoplasm causes the formation of HO. and HOg* which 
turn damage both lysosomal membranes and DNA.
Nucleic acids are very susceptible to free radical attack which 
can cause dimerisation of thymine and cross-linking across the strands 
of the double helix, thus preventing or retarding DNA replication and 
translation. Free radicals could also react with ribosomal, messenger 
or transfer RNA to cause errors in the transcriptional/translational 
process.
Muscle cells contain many mitochondria so high concentration of 
free radicals are expected, which could cause cross-linking between 
the fibres of act in 3 myosin or molecules of elastin which might 
account for the loss of subcutaneous elasticity in the elderly.
Therefore, over a prolonged period of time free radical production 
can damage cellular constituents leading to decreased efficiency.
Normal ageing and ageing accelerated by irradiation may be 
essentially similar in reflecting the deleterious effects of free radical 
producing reactions.
Radiation induces free radicals of the type , HC>2* (Stein 
& Weis, 19^8; Fridovich & Handler, 1958). Harman (l965) found that the 
serum copper level increases with age, a phenomenon which is in 
agreement with a free radical theory of ageing. This increase :of 
copper appears to be accompanied by an increased rate of athero­
sclerosis development but the significance of this correlation is not 
yet clear.
That radical reactions are relevant and not incidental side 
reactions, is supported by the effectiveness of antioxidants and 
radical scavengers in preventing damage (Goldstein et al. , 1970)*
(f) Other theories of ageing
(i) Waste product theory -
It has been suggested that some metabolic waste products are 
not excreted as rapidly as they are formed and their accumulation 
slowly poisons the organism or otherwise interferes with its 
operation. Strehler et al. (1959) have shown that lipofuscin 
accumulates in several different tissues, particularly in the 
myocardium. There is no evidence that these pigments interfere 
with normal functions. (Effects of antioxidant on lipofuscin 
accumulation in brain have been described in Chapter U).
(ii) Stress theory
Everyday stress of life causes wear.and tear upon the body 
and the underlying cause is cellular damage. The older an 
organism is, the less stress it can withstand before it becomes 
ill or dies (Selye & Prioreschi, i960).
(iii) Cybernetic theory
This theory suggests that ageing is due to a gradual loss of 
the nervous system's control over the organism's cells caused by ' 
the loss of functional brain cells (Still, 1969).
(g) Integrated theory of ageing
It appears that ageing cannot be caused by a simple change 
or a single reaction. When each of the theories of ageing are 
analysed none of them fully explain all phases of the ageing process. 
Carpenter and Loynd (1968) have tried to assemble all the theories of 
ageing into one integrated theory. This theory suggests that the 
cause of ageing is immobilisation of all types of macromolecules, 
such as protein, DNA, RNA, etc., by cross-linking. Cross-linking 
is proportional to the metabolic rate and dependent on the 
concentration of free radicals in the system. Increase in the 
environmental stress initiates a series of biochemical changes 
which enhances the rate of cross-link formation. Carpenter and 
loynd* have put together the different causes of ageing as cross- 
linkage, free radical accumulation, waste production, stress and 
mutation.
Chemical Modification of Ageing
The possible role of antioxidants in controlling the ageing 
process have been discussed, but, additionally, some drugs are 
claimed to be effective in controlling ageing processes.
(a) Azathioprine
Walford (196^) used azathioprine, an immunosuppressive agent, in 
ageing mice on the assumption that ageing is an anti-immune process.
A dietary dose of 100 mg/kg extended the 50 per cent survival 
point of treated animals 10 -weeks beyond that of controls9 but 
the life-span of the oldest survivors in the two groups did not 
differ significantly. The beneficial effect of the drug may have 
been cancelled by the age-related increase in the compound’s 
hepat ot oxi c ity.
.N
- CH,
°2H S
NH NH
Azathioprine
(b) Lathyrogens
Lathyrogens inhibit cross-linkage during collagen and elastic 
fibrogenesis and they have been studied for their effect on survival 
and longevity. By using 3 aminopropionitrile (BAPN) chronically.
La Bella (1968) has reported an increased survival-time of male 
and female rats.
h2nch2- ch2-cn
BAPN
(c) Meclofenoxate
Accumulation of lipofuscin pigment in the cytoplasm of neurons 
is a common cytological change with ageing. Lipofuscin accumulation 
is reversed by this drug, it also improves in treatment of confusion
states, apathy, disorders of memory and concentration, and senile 
agitation and fatigue (Nandy & Bourne, 196 6). When guinea-pigs, 
k -  6 years old, were treated parenterally with 80 mg/kg 
meclofenoxate daily for  ^- 8 weeks, the neurons showed marked 
reduction of lipofuscin pigments in most areas of the central 
nervous system (Nandy, 1968).
(d) Sulphonamides
Hackman (1962) reported that sulfadiazine added to the diet 
of mice, rats and dogs caused them to live longer and stay in 
better general condition. This may be due to bacteriostatic action 
of the drug.
S O Ih2n
Sulfadiazine
(e) Pantothenic acid
Pantothenic acid acts as an anti-ageing factor in Drosophila. 
When male and female 057 Black mice were given 300^g of calcium 
pantothenate drily in drinking water, the mean life span of treated 
group was 653.1 days and that of controls, 5^9*8 days (Pelton and 
Williams, 1958).
The treated group of mice had slightly greater body weights when 
they were approximately 250 days old. This effect could be 
prolongation of the presenile period or an improvement in general
health.
H0CHo - C - CHCONH CH_ CH CO_ H2 | | 2 2 2
CH3 oh
Pantothenic Acid
Nutrition and Ageing
The increase in the number of people living to old age 
and the consequent increase in the number of old people,
A
both absolutely and relative to the size of the population, 
has stimulated considerable interest in the nutrition of the 
elderly. This is not, however, the aspect of the problem
with which we are principally concerned in this thesis. The
growth of an organism from conception to maturity involves 
not only an increase in size but also changes within the 
various organs and tissues which are referred to as ’development1. 
After maturity a number of retrograde changes occur which in the 
present context can be described as’ageing!.
It is clear that these two aspects of the problem cannot be 
clearly separated for factors, such as nutrition, that delay the 
process of development may delay ageing. The classical studies 
by McCay and his colleagues (McCay et al., 1939) showed that 
development and life-span was prolonged by restricting the 
intake of an otherwise adequate diet. It should be pointed out, 
however, that life-span was extended in comparatively few animals
and that undernutrition did increase the likelihood of death
from other causes. Studies with rats undernourished by rearing 
them from birth in large litters (Widdowson& Kennedy, 1962') did 
not show evidence of elongated life-span.
There is no doubt, however, that undernutrition does delay 
ageing changes in collagen fibres (Chvapil & Hruza, 1959)•
These changes form the basis of the ’cross-linked hypothesis1 
of ageing (Bjorksten, 1968). This kind of change in connective 
tissue leads to loss of elasticity and this may be a significant 
factor in the development of some disorders of the circulatory 
system that are a significant cause of death in the elderly.
The formation of cross-links is also a factor in the accumulation 
of the age-pigment, lipofuscin. Here it has been suggested that 
free-radicals may be of considerable importance, and this has led 
to the development of the ’free-radical hypothesis’ of ageing 
(Harman,1968a). It is in the addition of anti-oxidants, which 
act as free-radical scavengers to food, that there seems to be 
some prospect of controlling ageing and increasing life-span.
Thus, tocopherol, ammonium diethyldithiocarbonate, butylated 
hydroxytoluene (Harman, 1968a),nordihydroguaiaretic acid 
(Buu-Hoi & Ratsimamanga, 1959) and etho;xyquin (Comfort, efc al»j 
1971)9 in concentration of 0 .2 5 “ 1 .0$, have all been shown to 
increase survival rate, and presumably to delay ageing. The 
experiments with ethoxyquin are, however, open to another 
interpretation, for the mice receiving the diet containing 
ethoxyquin were lighter, and increased survival could have been 
a secondary effect of a reduced food intake.
It could well be argued that if a-tocopherol increases life-span 
and delays ageing, then a deficiency causes accelerated ageing.
Clinical Signs of vitamin E deficiency have not so far been described 
in adult man, although increased haemolysis of red cells in babies 
has been attributed to it.
Lipid Peroxidation
Lipid peroxidation and free-radical reactions are receiving 
increasing interest as mechanisms of biological damage. With 
increasing evidence that free radical lipid peroxidation may be a basic 
damaging reaction in vitamin E or anti-oxidant nutritional deficiency 
status, in the biochemistry of ageing processes (Bjorkstem, 1962;
Harman, 1962; Sinex, 1961) and in vivo damage initiated by ionising 
radiation (Ord & Stocken, 1961), it is appropriate to consider this 
topic in broad perspective. Lipid peroxidations are very well 
characterised a s free radical chain reactions.
Biological material contains a wide variety of unsaturated lipid 
materials in the form of membrane lipid.
Subcellular organelles and membranes are very susceptible to 
lipid peroxidation and free radical reactions as mitochondria and 
endoplasmic reticulum contain high levels of PUFA. Lipid peroxidation 
damage in mitochondria can destroy the energy-generating apparatus 
of electron transport and oxidative phosphorylation. These destructive 
effects are almost completely suppressed by biological anti-oxidants. 
Vitamin E is the only known anti-oxidant which occurs naturally in 
mitochondria, endoplasmic reticulum and other membrane parts of cells. 
Studies on vitamin E deficient animals, aged animals and those heavily 
dosed with radiation, have shown that mitochondria, endoplasmic reticulum
and lysosomes are always involved.
Food products, such as milk, cheese and meat fat, also contain 
large amounts of unsaturated fatty acids. A characteristic property 
of such unsaturated fatty acids is that in the presence of a free 
radical initiator and oxygen they undergo oxidative deterioration, 
accompanied by a rancid smell and the change makes the food unpalatable.
Lipid peroxidation has also been suggested to be of major 
importance in the development of ethanol induced liver injury (Di Luzio 
& Hartman, 1967). Occurrence and estimation of lipid peroxidation can 
be effected in several ways.
(1) By the measurement of the concentration of lipid peroxide
after reacting with iodide (Johnson & Siddiql^ 1970)•
(2) By the measurement of diene conjugation formed by the
rearrangement of the double bond in natural unsaturated 
fatty acids and measure the absorption at 233 nm (Dahle 
et al, 1962).
(3) Measurements of the uptake of oxygen associated with
peroxidation and decrease in the content of unsaturated fatty 
acid (May & McCay, 1968).
(^ ) Measurement of a lipid peroxidation product, malonaldehyde,
that reacts with thiobarbituric acid to yield a red colour. 
The structures involved are shown below (Slater, 1972).
0
HN
N
H
(a) Thiobarbituric Acid (TBA)
(b) Malonaldehyde (MDA)
Fig. 1 - 1 Structures of (a) TBA and (b) MDA. The keto form of
malonaldehyde (I) is in equilibrium with the enol forms (S-cis, II
S-trans, III) of (?-hydroxyacrolein, IV is a chelated ring form.
There is a considerable amount of experimental evidence for 
the occurrence of damaging lipid peroxidation reactions in vivo.
(a) direct measurement of lipid peroxidation products which 
accumulate as the fluorescent ceroid and lipofuscin pigments (Pear 
i960), or as thiobarbituric acid reactants.
(b) Products of vitamin E are formed in vivo which indicate that 
vitamin E is involved in stopping the chain reaction of lipid
peroxidation (Draper, et al, 1967).
(c) successful replacement of vitamin E in the animal diet by 
structurally dissimilar lipid anti-oxidants has been reported (Dam 
Lipid peroxidation in brain parts has been described in detail in 
Chapter 3.
Role of antioxidants in selenoproteins in normal functioning
of liver
Vitamin E and some other biological anti-oxidants stabilise poly­
unsaturated lipids and minimise lipid peroxidation damage. As a 
biochemical model of these deteriorative reactions, Roubal & Tappel 
(1966) studied lipid peroxidation damage to proteins and enzymes, 
characterised some of the oxidised lipid-protein reaction products 
as protein-protein cross-linked polymers and implicated a free-radical 
mechanism in their formation. The fluorescence produced from the 
cross-linking has been attributed by Chio & Tappel (1969) to the 
imine structure formed in protein between 2-epsilon-amino groups and 
malonaldehyde (the peroxidation product of polyunsaturated fatty 
acid).
The structure of the fluorescent chromophore was determined;
1 mole of malonaldehyde reacts with 2 moles of amino compound to 
yield N, IT*"- disubstituted l-amino-3“imino propenes (R-N=CH-CH=CH-NH-R).
The major biological anti-oxidant, vitamin E, shows complex 
relationships with other anti-oxidants and reducing compounds (Tappel, 
1962). Tappel has attributed the major biological function of vitamin 
E to radical chain-breaking in its inhibition of lipid peroxidation. 
Vitamin C can also act as a synergist for vitamin E. Small amounts 
of sulphydryl compounds - mainly sulphydryl proteins, glutathione, 
methionine and cysteine - apparently react as free radical scavengers 
and peroxide decomposers. Seleno-amino acids are apowerful 
catalysts of sulphydryl-disulphide exchange (Tappel et al, 1967;
Tappel, 1970). Ubiquinol, in small amounts acts as a chain-breaking 
lipid anti-oxidant synergistically with vitamin E.
It has been suggested that selenium is as effective as vitamin 
E in preventing dietary liver necrosis. In vitamin E deficiency 
diseases, as for example exudative diathesis in chicks and other 
fowl (Scott, et al, 1957; Patterson, et al, 1957;)
. white muscle disease in sheep and cattle (Muth et al, 1958; 
Proctor et al, 1958); selenium also plays an important role.
However, selenium does not protect chickens ajgainsi/encephalomalacia
j^T'oeLx/tJtd. by A/T-ffX/ £&[/&■£$ cjpj A.
(Dam et al, 195?)» "which i s ]  I ./dietary linoleic or
arachidonic acid (Dam et al, 1958; Century et al, 1959)» but the 
synthetic anti-oxidant ethoxyquin will prevent encephalomalacia, 
muscular degeneration and exudative diathesis, even when added to 
purified diets which are essentially free of vitamin E, (Machlin 
et al, 1959; Machlin & Gordon, 1962). The latter studies have 
suggested that selenium may be linked with some anti-oxidant mechanism. 
The primary function of vitamin E in vivo might be to inhibit the 
oxidation of selenide-containing proteins, and the selenide may 
form a part of the active centre of a non-haem iron protein.(Diplock 
& Lucy, 1973).
Other reports (Caygill et al, 1971; Caygill & Diplock, 1973; = 
Caygill et al, 1973) have indicated that the rat liver microsomal 
non-haem iron protein is oxidant labile and that this protein may 
function in the hepatic microsomal NADPH-dependent electron 
transport chain, and is protected by vitamin E. A similar vitamin 
E-protected mechanism has earlier been reported to stabilize 
phospholipids in the lipid membrane (Hochstein et al, 1961+;
McCay et al, 1972).
Abnormal amounts of anti oxidants
The tissue disturbances, resulting from abnormal intake of 
dietary anti oxidant, will be discussed here. It is subdivided 
into
(a) Excessive intakes - result consumption of the antioxidant in 
low concentration for a long time (chronic toxicity) or ingestion 
of high amounts of antixidants (acute toxicity).
(b) Dietary deficiency - as for example, vitamin E.
Toxicity of antioxidants
(a) Vitamin E - No toxic effect in human has so far been reported, 
even at high levels of-800 mg/kg/day for 5 months, (Recommended 
Dietary Allowances, 1968). Harman (1968a), in a life-span study 
in mice, using vitamin E at a dietary level of 0.5%, revealed 
no toxicity,rather prolongevity was claimed. A recent report 
(March et al, 1973) , using vitamin E at a level of 220 - 2200
per kg diet in the chick suggested that it could be toxic, resulting 
in reticulcytosis and a lowered haematocrit value.
(b) Toxicity of phenolic antioxidants - The acute toxicity has 
been reviewed by Dacre(l960) and Johnson (1971)• From these 
reports it appears that acute toxicity is generally low, 
values for BHA, BHT, gallate esters and NDGA all are in the range 
1 .2 5 g to 6 .5 g/kg in a number of species, including rat, mouse 
and rabbit.
Butylated hydroxyanisole (BHA)
Diet containing 0.06% BHA was without adverse effect on 
growth rate and reproduction in rats; there was no pathological 
symptoms after 22 months administration (Wilder and Kraybill,
19W).
Effects on body weight at higher dose levels (3%) were 
attributed to non-acceptability of the diet. Denz and Llaurado 
(1957)9 using higher dose level (l g/kg), found effects on adrenal 
and kidney function in the rabbit.
Dietary administration of 0.5% BHA to rats caused a transient 
liver enlargement with increased ascorbic acid excretion, but was 
without effect on glucose-6-phosphate dehydrogenase. (Gaunt et al
1965; Feuer et al, 1965). ' “
Butylated hydroxytoluene (BHT)
At a dietary level of 100 mg/kg on rats on a multigeneration 
study, BHT had nc effects (Frawley et al, 1965)• At a higher level 
of 3000 mg/kg growth rate was retarded and serum cholesterol levels 
were elevated. The hypercholesteraemic effect of BHT in the rat has 
also been reported at a dose level of 0.1 - 0.5% (Day et al, 1959; 
Gaunt et al, 1965), female animals being more sensitive than 
males. Increased serum phospholipid was also observed in these 
studies, but the effects were not detectable at lower • dose levels.
The effect of BHT in reducing body weight gain may not be 
wholly attributable to unacceptability of the diet, as Johnson 
& Holdsworth (1968) reported that a 0.5% dietary dose level increased 
the basal metabolic rate. Nephrotoxicity in rabbits at dietary dose 
levels of 0.25% “ 0.5%"BHT has been reported (Denz & Llaurado,
1957)# - BHT has been reported to cause
prolongevity in mice (Harman, 1968 a and b).
Daily doses of BHT (500 mg/kg/day) increased liver weight 
in both rats and Slice. (Gilbert & Golberg, . 1965), while Gaunt 
et al. (1965) found a similar increase in rats fed 0.5% of BHT 
in the diet. The increased liver weight was accompanied by very 
slight fatty changes, increased urinary ascorbic acid, proliferation 
of hepatic endoplasmic reticulum, induction of a number of 
drug-metabolising enzymes,increased glucose-6-phosphatase activity 
(Gilbert & Golberg , 1965; Gaunt et al, 1965; Feuer et al, 1965;
Gray et al, 1972); but all these changes were reversible when 
BHT was withdrawn (Gaunt et al, 1965).
Gallate esters
In long-term feeding studies on gallate esters ( i k  months - 
2 years), no adverse effect was found in rats, guinea-pigs and 
levels of up to 6% octyl or dodecyl gallate or up to 
0.117% propyl gallate (Orten et al., 19^ -8). Graham et al (195^9 
1955) similarly found propyl gallate to be without effect on 
rats at levels far in excess of human exposure. Feuer et al 
(1965) observed slight fatty changes in the liver of rats 
given propyl gallate at doses of 500 mg)(kg/day intragastrically
dogs at^ /
for one week, but changes were reversible when the antioxidant 
was withdrawn.
The gallate esters therefore appear to be harmless when ingested 
at normal human dietary level.
Nordihydroguaiaretic acid (NDGA)
At dose levels of 0.1% and 0.25% of the diet, this anti-oxidant 
had little or no effect on growth in the rat. At the 0.5% dose level 
NDGA has a slight effect in reducing growth rate and these effects 
were pronounced in rats fed at the level’of 1% of the diet (Cranston 
et al., 19hT). Grice et al. (1968).fed.NDGA at levels of 0.5% and 1% 
of the total diet for 7^ "weeks to rats and severe toxicity was observed 
at both the levels. NDGA is converted to the quinone or the acid, or ;'; 
possibly both, in the intestine of the rat and the toxic effect is 
shown by the nature of the reticulo-endothelial cells. These became 
hyperactive and started phagocytising foreign materials. In the 
kidney, the glomeruli appeared normal but the tubular cells were 
distended and appeared to block the.tubular lumen. Kidney weights 
were significantly higher in.NDGA-treated animals relative to body 
weight than the control animals. As a result of these effects of 
NDGA, the U.S. Food and Drug Administration removed this anti-oxidant 
from their GRAS (generally recognised as safe) list (U.S. Federal 
Register, 1968). In many countries, including the U.K., NDGA has 
been removed from the list of permitted food additives.
Toxicity of the heterocyclic anti oxidant, ethoxyquin
In studies of the acute oral toxicity of ethoxyquin, Wilson
& De Eds (l959) reported that a dose level of 1000 mg/kg caused the
death of £ out of 7 rats; and 1 out of 5 at 6^0 mg/kg. The LD 50
for mice dosed intravenously was 178 mg/kg. Diets containing 0.2%
or more, of ethoxyquin decreased the rate of growth in young rats
for the first 2 to 1 weeks. In male rats, liver weights were increased
on diets containing 0.1% or more, and damaged, heavier kidneys were
noted on diets containing from 0.025%; thyroids were also affected.
In the female rats the changes were milder in nature. Repeated
application of ethoxyquin to the skin of rabbits and guinea-pigs
♦
produced local lesions but when injected after mixing with equal 
amounts of Tween 80 and suspended in saline, no sensitisation 
developed.
Studying the absorption, metabolism and excretion of ethoxyquin 
in rats Wilson et al (1959), observed the rapid absorption and 
excretion of this antioxidant. After a heavy dose unchanged ethoxyquin 
was found in small amounts in the urine.
Chafferd & Thiolliere (1970) have reviewed the toxic effects of 
large doses of ethoxyquin to establish the LD50. The LD50 dose for rats was 
800 to 1000 mg/kg (orally), for mice 800 to 1000 mg/kg (intraperitoneally) 
and for chickens 600 to 10,000 mg/kg (orally).
Vitamin E deficiency diseases
The requirement for vitamin E varies widely from animal to animal 
and deficiency produces a variety of symptoms in different species 
(Olsen, 1973). Table 1-1 summarises the wide spectrum of manifestations 
of vitamin E deficiency.
Table 1 - 1
Vitamin E Deficiency Diseases by Systems Involved
I Reproductive system.
A. Abortion-resorption in female animals,
B. Testicular degeneration in male animals,
II Muscular system.
A. Skeletal muscular dystrophy (rabbit, guineapig, monkey, duck,
mouse, mink, lamb, calf, kid, turkey, chicken).
B. Cardiomyopathy (lamb, calf, kid, turkey, rabbit).
III Vascular system.
A. Defective embryogenesis (rat, hen, turkey, cow, ewe).
B. Exudative diathesis (chicken, turkey)-
C. Erythrocyte haemolysis (rat, chicken, man).
D. Bone marrow failure (monkey)'
IV Hepatobiliary system.
A. Hepatic necrosis (rat, pig).
V Central Nervous System.
A. Encephalomalacia (chicken).
The action of vitamin E at the cellular and subcellular 
level can be partially or completely replaced by non-tocopherols, 
including selenium, given as selenite (SeO^-), ubiquinones and 
ubichromanols, the sulphur amino acids methionine and cystine, and 
DPPD or ethoxyquin. The extent of replaceability depends on the
species and the particular disorder induced by lack of vitamin E.
The Table I - II summarises the interactions (Olsen, 1973). It 
has been suggested that the chemical antioxidants protect residual 
amounts of vitamin E thereby curing the an‘tioxidant responsive 
diseases. The selenium-responsive diseases respond better to 
slenium in micrograms per kilogram diet than to vitamin E in 
milligrams per kilogram diet.
Table I - II
Interaction of Vitamin E with other nutrients in the treatment of 
various deficiency diseases
I Antioxidant responsive disease (DPPD, Ethoxyquin),
A. Encephalomalacia (chickens , turkeys)*'
B. Abortion-resorption (rats).
C. Erythrocyte hemolysis (rats, man).
D. Ceroid pigmentation (rats, mink, pigs).
II Principally vitamin E-responsive diseases,
A. Muscular dystrophy (rabbits, guineapigs, chickens, monkeys).
B. Testicular degeneration (rats)*
III Principally selenium-responsive diseases.
A. Embryogenesis defect (cow)*
B. Muscle dystrophy (lamb, calf, kid, turkey).
IV Vitamin E and selenium-responsive diseases,
A. Hepatic necrosis (rat, pig)-
B. Exudative diathesis (chicken).
Detoxication of antioxidants
Vitamin E, ascorbic acid the naturally occuring antioxidants 
have a nutritional role in mammalian species and are not usually 
considered as foreign compounds. Synthetic antioxidants (BHA, BHT, 
gallate esters, ethoxyquin, etc.) used as food additives are not 
essential nutrients and,•if accumulated in the body, might reach 
toxic levels; they are classified as foreign compounds. Detoxication 
of foreign compounds frequently takes place in the endoplasmic 
reticulum of liver, (Gram & Fouts 1968), but there are other sites, 
including kidney, lungs and gastrointestinal tract, and placenta 
of the pregnant mother (Hutson, 1970). Metabolism of foreign 
compounds involves two phases; the fir*st phase includes such reactions 
as oxidation, reduction and hydrolysis. The second phase involves 
conjugations (Williams, 1967).
In the first phase reactions (asynthetic), there occurs introduction 
or unmasking of functional groups rendering a non-polar compound polar, 
or a polar compound to be more polar in order that it is more readily 
excreted than the original compound. In the second phase reactions 
(synthetic); these functional groups often act as centres, for 
conjugations with endogenous molecules, glucuronide, sulphate or 
amino acids, e.g. glycine, for excretion of the products, usually as 
water soluble acids. The conjugates are excreted in the bile or urine. 
Most foreign compounds are metabolised by both phases of reactions, 
as for example, BHT (Dacre, 1961; Wright et^  al., 1965 s Wright & Crowne, 196 
Compounds already possessing one or more functional groups, often 
undergo only phase II reactions. Thus, BHA is partly excreted in the 
urine, mostly as glucuronides and sulphates (Dacre et al, 1956;
Dacre, 1960, Daniel et al, 1967).
Role of antioxidants in longevity - antioxidation or induction
Ethoxyquin and a number of antioxidants, including BHT and 
vitamin E, increase life-span of mice when administered at a dietary 
level of 2.5 to 15.0 g/kg (Harman, 1957s 1968a,b; Comfort et al., 1971). 
Prolongevity in rats is also caused by NDGA when this is fed at a 
substantially lower level of 20 mg/kg diet (Buu-Hoi & Ratsimamanga, 1959).
Propyl gallate, a permitted food antioxidant when given at a 
dietary level of 0 .25% to 0 .50%, has not, however, shown any prolongation 
of mouse life-span, (Harman, 1968b).
Several mechanisms of life-span increasing effects have been 
suggested, and these include free radical scavenging (Harman, 1968b), 
which results in stabilisation of all membranes and subcellular 
organelles, such as lysosomes (Hochschild, 1971) and mitochondria 
(Tappel and Zalkin, 1959), and in the prevention of the formation 
of lipofuscin age pigments (Rudra et al., 1975) and cross-linking 
in the ageing collagen (Chio et al, 1969). Mechanisms may also 
include hepatic enzyme induction (Comfort et al., 1971; Parke et al., 
1972), responsible for detoxication of xenobiotics.
(a) Free radical scavenging:- Dietary ethoxyquin increased 
of mouse at age of 20 months by 75% > BHT by 6l%, BHT plus supplementary 
vitamin E by 33% and supplementary vitamin E by 13% (Harman, 1968a).
This would suggest that antioxidation by free radical scavenging would 
explain prolongevity only in terms of the intrinsic antioxidant function 
of each compound.
Comfort et al., (1971) suggested that the increase in 
mouse life-span by the antioxidant, ethoxyquin, might result from 
prevention of the formation of toxic materials in the "normal11 
laboratory diet, which may include lipid peroxidation products.
The inability of dietary propyl gallate to increase mouse life­
span does not support this proposition.
(b) Enzyme induction: BHT induces drug-metabolising enzymes
(Gilbert & Golberg, 1965) and it is on the basis of this finding 
that Comfort et al. (1971) suggested that enzyme induction might 
be involved in the prolongation of mouse life-span. Ethoxyquin caused 
’enzyme induction (Cawthorne et al. 1970, 1973); it also increased the 
concentrations of hepatic microsomal protein, cytochrome P-^50 and 
cytochrome b^ and biphenyl ^-hydroxylase but with n-propyl gallate 
no induction of these enzymes was observed (Parke et al.1972) probably 
because the propyl gallate is hydrolysed before absorption, and 
hydrolysis products would not be expected to be substrates for 
micro-somal enzymes.
Reports of enzyme induction by vitamin E (Cawthorne et al., 1970) 
and BHA (Creaven et al, 1966) also appeared.
Unfortunately, the metabolism of these compounds in experimental 
animals is not always the same as in man due to differences in many 
enzyme systems. Metabolic studies using labelled compounds with 
BHA and BHT has been conducted (Daniel et al, 1967). These experiments 
demonstrated that both of the antioxidants are completely excreted 
by man within lVdays, with no accumulation.
Kidney cortical and medullary cysts were produced by the use of 
NDGA in rats only (Grice et al, 1968; Goodman et al, 1970).
NDGA induces drug metabolising enzymes .(Parke et al, 1973); 
antioxidants like ethoxyquin, NDGA, BHT which has been claimed to 
prolong life, increase liver size and total metabolic activity of 
several drug metabolising enzymes; whereas propyl gallate, an 
antioxidant that has been reported not to prolong life (Harman,
1968b) does not induce hepatic microsomal enzymes (Parke et_ al,
1972). Lipid peroxides are necessary for the maximal induction 
of cytochrome P-ij-50 by phenobarbitone, although they do not induce 
per se (McLean & Marshall, 1971). The induction of the liver 
enzymes by BHT, ethoxyquin and NDGA (Parke, et_ al, 1973) was not 
enhanced by the presence of dietary peroxides as experimental 
conditions didnot favour their formation.
It has been suggested that ageing may involve oxidation of 
lipids in vivo by free radical attack (Dormandy, 1969) and the 
ability of these antioxidants to delay ageing and to induce hepatic 
microsomal enzymes may reflect their ability to stabilise phospholipid 
in the membranes of the cell and subcellular organelles including 
endoplasmic reticulum.
Walker et al. (1973 a Reported that rats receiving 0.5% antioxidant
ethoxyquin or NDGA in the diet, during the period 8l to 1^+0 days the
microsomal protein remained double the control level while, in contrast,
the induced levels of cytochrome P-^50 and b_ continued to fall, the
P
decline being most marked with cytochrome P-if50. Induced levels of 
biphenyl-lf-hydroxylase and ethylmorphine-N-demethylase also fall slowly 
over this period and in the former case the induced activity was
was still lower than that observed in untreated weanlings. The 
fall in the activity and inducibility of the drug-metabolising 
enzymes with age underlines the fact that the toxicity of a 
drug may increase with age with obvious results in geriatric 
treatment. One weakness in the argument that enzyme induction 
per se might cause prolongevity is that not all enzyme inducers 
cause prolongevity.
Scope of the Thesis
As ageing processes and biochemistry of vitamin E deficiency 
run parallel, it is important that research should continue to 
explore fully the optimum intake of vitamin E and its relationship 
to synthetic antioxidants.
Oxidation of PUFA is studied by chemists interested in the 
mechanism of antioxidation, by food chemists interested in the , 
protection of fat-containing food from rancidity and by biochemists 
to study the role of free radicals in ageing processes. The proper 
balance between intake of PUFA and biological antioxidants is essential 
to slow down the ageing processes. A visible result of the harmful 
effects of peroxidation is the production of lipofuscin pigments 
deposited in the brain and heart.
By the use of natural and synthetic antioxidants lipid peroxidation 
producing fee radical damage and the product of peroxidation, like 
lipofuscin pigment accumulation in the heart and brain could be 
reduced., It is reasonable to expect that when one or more free radical 
inhibitors are added to a properly selected natural diet, containing 
all the essential nutrients, it may increase the useful life-span of
humans.
Some formulations have already been made in the U.S.A. and a 
l£ai>n/
, in the form of five to ten years human life-span by antioxidant 
therapy alone has been made (Passwater & Welker, 1971). For the safe 
use of antioxidants, the differences in species, age, sex, dose must 
be borne in mind, otherwise its indiscriminate use may endanger life.
Total life-span in a species may be genetically determined but 
environmental factors, such as nutrition, can influence the expression 
of the basic genetic programme of a species. Animal experiments, as 
for example in the rat (McCay jet al, 1939) have shown that life-span 
can be lengthened by restricting food intake over the entire life- 
span.
In man, obesity reduces life-span; in women, the risks are 
somewhat less (Davidson et_ al, 1972).
It can be concluded that ageing, though at present poorly 
understood, is an intricate process of change in structure and in 
homeostatic control. Present knowledge does not enable us to 
distinguish primary and secondary factors in the experimental models 
which have been used to test the validity of specific theories 
of ageing. As a result, it is usually difficult to evaluate the 
effects of chemical agents on the process as a whole.
The future course of research must be directed toward both short and 
long-range objectives. The former would stimulate vigorous search 
for new therapeutic agents to alleviate the debilitating sequelae 
of senescence. A much more difficult task will be the elucidation 
of the primary and fundamental mechanisms of senescence.
. This thesis describes a life span study in the rat in which 
the effects of addition of natural antioxidant (vitamin E) and 
a synthetic antioxidant (ethoxyquin) at various concentrations 
in the diet on growth, life span and other age related parameters 
were studied. Additional short term experiments were carried 
out to explain some interesting findings which emerged from the 
lorig term experiment.
CHAPTER 2
Long term study of ethoxyquin and vitamin E and their effects
on the life-span of the rat
Introduction
Previous work has suggested that high levels of antioxidants 
in the diet might reduce the rate of endogenous lipid peroxidation 
and also the decline in some detoxication reactions associated with 
ageing (Bender et al, 1970; Comfort, 1970)- Harman (1968a,b) showed 
that the freeradical inhibitors, mereaptoethylamine and butylated 
hydroxy toluene,increased the mean lifespan of one strain of mice. 
Naturally occurring dietary antioxidants show various synergistic 
effects and it has been suggested that appropriate mixtures of 
these nutrients should protect the tissues against damage due to 
peroxidation (Tappel, 1970), There is evidence that small supplements 
of vitamin E have little effect on ageing processes. Thus, Berg 
(1959) supplemented ageing rats with 100 mg vitamin E weekly and 
found that it had no effect on the incidence of muscular dystrophy, 
chronic disease and life-span.An increased concentration of a chain- 
breaking antioxidant such as vitamin E neutralises free radicals and 
prevents peroxidation of lipids within the membranes (Tappel, 1972).
Many antioxidants act by sparing small amounts of vitamin E 
in the diet or in the gastrointestinal tract (Dam, 1957)* A few 
antioxidants appear to have real vitamin E-like activity in vivo, 
but not all of them are active against all vitamin E deficiency 
diseases. The range of their biological potency is large and 
often their activity is much lower than that of vitamin E.
N, N -diphenyl-p-phenylenediamine (DPPD) seems to be unique in 
preventing foetal resorption in the rat (Drapper et al.„ 196H) and
encephalomalacia in the chick at a dietary level of 
250 ppm (Singsen et_ al•, 1955) Hut is ineffective against 
exudative diathesis in chickens (Bieri, 196^). Ethoxyquin, 
which is highly active against liver necrosis in the rat 
(Schwarz, 1958) is much less active than vitamin E against 
encephalomalacia and exudative diathesis in the chick.(Scott 
et al., 1955)• The aim of the current work was to provide 
more than sufficient amounts of antioxidant (vitamin E and 
ethoxyquin) for maximum incorporation into -the membranes of 
cells and cell organelles and thus to provide optimum protection 
for the polyunsaturated phospholipids. The maximum life-span 
obtained by the addition of antioxidants has so far been within 
the credible or recorded natural performance of the strains 
(Muhlbock, 1959)- The study reported here was designed to 
investigate the effect of vitamin E and ethoxyquin in detoxicating 
dietary anutrients and to correlate the effect with the survival 
rate.
Materials and Methods
a) Chemicals
Vitamin E (Dl-a-tocopherol acetate, Sigma); Ethoxyquin 
(6 ethoxy-1,2,dihydro 2,2,k trimethyl quinoline, 96% g0I.e. 
pure grade, Koch Light Laboratories); glycerol, xylene (BDK); 
Industrial methylated spirit (IMS). Antioxidant free arachis 
oil (Saladin quality, Craigmiller) used as a vehicle for 
incorporating vitamin E and ethoxyquin into the test diets.
Other reagents are mentioned in the text where appropriate.
b) Animals
Inbred Wistar albino male rats were used in these studies 
and accommodated in the University Animal Unit. Environmental 
conditions were maintained at a relative humidity of 50% 1 and, 
a temperature of 20 - 22°C with a 12 hour light/dark cycle.
c) Administration of antioxidant in the diet
The young rats were brought to the animal unit from the 
farm with their dams when they were 18 days old. They were 
given the powdered control diet (Spillers small laboratory 
animal diet No. 2, meal form), to which was added 2,5% w/w 
arachis oil, untii they were 21days of age. They’- were then 
separated from the dam, and put into individual polypropylene 
cages in mobile racks. The diets were given in special food 
pots containing a perforated lid (-2? in, dia.) and one inner 
(2g in. dia.) and one outer (3§ in. dia.) compartments. This 
arrangement minimised the loss of food due to spillage. The 
supplementary antioxidant (ethoxyquin or tocopherol acetate) 
were incorporated into the arachis oil before mixing with the 
meal to give the appropriate concentration. Fresh diets were 
made up at weekly intervals to prevent the accumulation of toxic 
peroxidation products. The experimental protocol was similar 
to that previously reported (Rudra ert al., 197*0 and was as,-follows 
The weanling rats were randomly divided into seven groups, each 
containing 5 animals and were thereafter maintained on the diet as 
shown in table 2-1. Water was always freely available to all 
groups.
Table 2-1. Basal diet supplementation and, accessibility to 
different groups of rats
Group Basal diet Supplementation Accessibility
I ' . Spillers Small 
Laboratory Animal 
Diet No. 2 + 2 . 5 %  
arachis oil
Nil ad-libit urn
II it 0.5% DL-a-tocopherol- 
acetate
ad-libitum
III it Nil Pair fed with 
group II
IV it 0.05$ DL-a-tocopherol- 
acetate
ad-libitum
V i Nil Pair fed with grou 
IV
VI ■ it 0 . 5% ethoxyquin ad-libitum
VII it Nil Pair fed with grou 
VI
The rats receiving vitamin E and their respective pair-fed controls 
(Groups II - V inclusive), and the rats in group I were maintained for a 
maximum period of 702 days; the animals receiving ethoxyquin and their 
pair-fed controls were maintained for a maximum of 577 days.
(d) Haematology
i) Haematrocrit or Packed cell volume (PCV), was determined by 
the micro method, using standard (75 mm) heparinised haematrocrit 
capillary tubes. Blood was obtained from the tail of a rat after 
cutting the end with a scalpel. It was allowed to enter the 
capillary tube, and controlled with the index finger placed over 
the other end. At least 15 mm was left unfilled. Keeping the 
index finger in position the tube was inserted into cristaseal, 
twisted gently and checked to see that it was properly sealed.
The tube was then placed in one of the grooves of the MSE 
h aematocryt centrifuge head with the sealed end;against the 
peripheral gasket, and centrifuged for 15 minutes at 2000 r.p.m.
After centrifugation, the length of the tube occupied by the 
erythrocytes was measured and expressed as a percentage of that 
occupied by the whole sample with the Hawksley microhaemat ocrit 
reader. '
ii) Haemoglobin determination Haemoglobin was measured by
the Cyan-methaemoglobin method. The basis of this method was the 
dilution of blood in a solution containing cyanide. The haemoglobin, 
methaemoglobin and carboxyhaemoglobin was converted rapidly to 
cyanmethaemoglobin. A Boehringer Mannheim Kit 15927 was used.
A cyanide solution was prepared and a non-ionic detergent was 
added to promote haemolysis and prevent turbidity by plasma protein 
precipitation. 5 ml of this solution were pipetted into plastic 
capped bottles using an Oxford automatic pipette and 0.02 ml of 
blood (Collected by cutting the tip of the tail of rat in a 20 pi 
heparinised microcap) was added. After mixing thoroughly and allowing
to stand at room temperature for 3 minutes, the optical density 
was read in a Cecil spectrophotometer at 5^6 nm using water as 
a blank.
A standard curve was plotted using Boehringer Mannheim 
standard set 15998. The set contained four ampoules each containing 
8 mis of cyanmethaemoglobin solution of concentrations 5# 1 5»
20 g haemoglobin per 100 ml blood. The ampoules were brought to 
room temperature, and the optical density measured in the same 
instrument under the same conditions as the test solutions using 
water as blank. The points fitted a straight line passing through 
the origin.
iii) Reticulocyte count: Reticulocytes were counted in
blood collected as previously described from the tail of a rat.
The blood (3 drops) was mixed with 3 drops of a solution of New 
Methylene Blue and incubated at 37° in a water bath for 15 minutes. 
(The solution of New Methylene Blue was prepared by dissolving 
1 g of the dye in 100 ml of citrate-saline solution - 1 part of 
3l  sodium citrate added to  ^parts of 0.9$ sodium chloride solution).
At the end of the incubations , the red cells were resuspended 
by gentle mixing and a blood film was made. When dry, the films 
were examined using an oil-immersion objective of the microscope 
at a magnification of X 625. The reticular material stained deep 
blue, in 15 fields the number of reticulocyte and red cells were 
counted on a hand counter and the reticulocyte count was expressed 
as a percentage of the red cells.
iv) Measurement of blood coagulation time Two drops of blood 
were obtained from the tip of the tail and put on a clean 
porcelain tile. A stop-watch was started immediately and with a 
fine end of glass rod the drops of blood were moved in small circles. 
The end point was taken as the appearance of strings of fibrin and 
the stop-watch was stopped and time noted and expressed in seconds.
The experiment was performed at room temperature (20°C) as the 
speed of clotting increases with the temperature,
v) Red blood cell count Red blood cells were counted automatically 
using the Celloscope '1+01' (Linson instrument AB. Stockholm, Sweden).
A diluent was prepared containing 9 g® of sodium chloride and 10 ml 
h0% formalin per litre. Blood 0.02 ml (obtained by cutting the 
tip of the tail of rat in 20 yl heparinised microcap) was diluted 
in a screw cap tube containing k ml of diluent. The solution was mixed 
thoroughly and 0 .0 5 ml of it again mixed with 20 ml of diluent, 
giving a final dilution of 1 : 80,000. The celloscope, amplifier 
and discriminator were calibrated with click positions, according 
to the size of human red blood cells. Readings were taken using the 
click positions and so the values were comperative rather than 
absolute. Care was taken not to use clotted samples as these gave 
high values, and if the sample is haemolysed the readings will be 
low as lysed cells are not registered.
e) Urine examination
The methods generally applied to the study of renal function 
in man and larger animals are not easily applied to the laboratory 
rodent. In the current studies, kidney function and damage were
+ +
evaluated by determining urinary electrolytes (Na and K ), total 
protein and creatinine.
(i) Collection of rat urine Rats were kept in individual 
metabolic cages for urine collection free from faecal contamination 
at least 2^+ hours before the experiment commenced. Urine was 
collected for a subsequent i+8 hours, in 2k hour increments. Toluene 
3~^ drops was added in the urine collecting vessel to prevent 
bacterial growth and samples were analysed soon after collection
or kept at A°C if necessary.
(ii) Determination of sodium and potassium in urine The 
concentrations of sodium and potassium in urine were determined 
with an EEL flame photometer.
(iii) Determination of total protein in urine A turbidometric
method (Varleys 1967) was used. The urine was diluted 1 : 20 with 
distilled water. To 1 ml of diluted urine 3 ml of '3% trichloracetic 
acid (TCA) in aqueous solution was added. The turbidity was read
at 1+50 nm in a Cecil CE 272 linear readout U.V. spectrometer in 
cuvettes of 1 cm light path against saline and TCA as blank. A 
standard curve was prepared using bovine serum albumin (BSA) obtained 
from Koch Light Laboratories, England; dissolved in 0.9% seline 
at a stock concentration of 200 mg/100 ml. Dilutions were made in 0.9% 
saline to give concentrations ranging from 200yg - 2000yg over which 
range a linear relationship existed. As the urine obtained from 
ethoxyq.uin treated rats was dark brown in colour, a sample blank 
was prepared in all analysis by deproteinising 2 ml of concentrated 
urine with 10 mg of TCA & centrifuge. The supernatant was diluted 1 : 20
with distilled water and treated in the same way as the samples.
All estimations were carried out in duplicate.
(iv) Determination of creatinine in urine The Alkaline Picrate 
Method as described by Varley (1967) was employed. The urine 
samples were diluted 1 : 200 with distilled water. 3 ml of diluted 
urine was taken in a test tube and to each was added 1 ml of 
0.0*+ M picric acid solution (9 .16 g per litre of distilled water) 
and 1 ml of 0.75 N sodium hydroxide. The solutions were mixed 
and allowed to stand for 15 minutes then the absorbance was
determined in a Cecil CE 272 linear read out U.V. spectrophotometer
at 500 nm against a blank consisting of 3 ml of water and 1 ml of 
each reagent. A sample blank was prepared similar to that for total 
protein estimation in urine, diluted 1 : 200 with distilled water.
3 ml of this deproteinised diluted urine and 1 ml O.Ot M picric 
acid + 1  ml 0.1 N HC1, instead of 1 ml 0.75 N sodium hydroxide, 
were added and read as the samples. Stock standard creatinine 
solution was prepared by dissolving 1 g pure dry creatinine in 
0,1 N hydrochloric acid and made up to 1000 ml, ranging from 
12 yg - 60 yg in 3 ml over which range a linear relationship 
existed. All estimations were carried out in duplicate.
(f) Light microscopic studies of kidney, liver and bone
The left kidney was cut into two halves transversely, 
then specimens about 5 nun square from ethoxyquin treated and pair- 
fed controls of t0 7, *+^ 5» days were preserved in 10% buffered 
formalin (t.6 g sodium dihydrogen orthophosphate dihydrated; and 
6.5 g disodium hydrogen orthophosphate per litre) for light 
microscopic studies according to Carleton (1973) and as described
below.
Liver specimens from the left lateral lobes from ethoxyquin 
treated and pair-fed control of t8l days were similarly preserved 
in buffered formalin and examined.
The left femur, humerus and ulna of 557 day-old ethoxyquin- 
treated and control rats were soaked in 10% buffered formalin 
then put in formic acid - sodium-citrate mixture for decalcification 
Carleton (1973). The composition of the mixturq was: formic acid 
(S.G. 1.2) 35 ml; 20 % sodium citrate 65 ml. The formic acid 
and sodium citrate mixture was changed on the 3rd day and bones 
kept up to 7 days in the solution became soft and malleable. After 
decalcification the tissue was transferred directly to 70% alcohol 
for dehydration prior to paraffin wax embedding. As a decalcifying 
agent, formic acid is preferred to nitric acid as it is less damaging 
to tissue structures and staining. Haematoxylin and eosin stain 
were used for liver, kidney and bone specimens.
(i) Dehydration, clearing and impregnation and embedding of the 
tissues were done according to standard histological procedures.
(ii) Tissue sections of 7 V thickness were cut on a rotary 
microtome (”820" Spencer, American Optical Corporation) and
stained with haematoxylin and eosin according to the standard 
histological procedure.
(iii) Kidney sections were stained with Peris' Prussian Blue stain 
to study the haemosiderin pigment. In this stain potassium 
ferricyanide combines with ferric iron to form ferric ferrocyanide 
(Prussion Blue), this is not a dye but an insoluble deeply
coloured visible deposit.
3K^Fe(CN)6 + l+FeClg = Fe^ j^ Fe.(CN)6 + 12KC1
3
(iv) The stained sections were mounted on a glass slide with 
the mounting media DPX (mixture of distrene, tricresyl 
phosphate and xylene; BDH).
(v) The slides were studied under a Leitz Orthoplan Microscope 
fitted with a Orthomat Camera, with an eye-piece of magnification 
x 1 2.5» binocular head magnification of x 1 .2 5 and objective 
magnifications of x 10, x 25, x 1+0. The fields selected were 
photographed using Ilford Pan F film (50 ASA), developed, fixed 
and finally printed from the negatives.
(g) X-ray photography of bones
The bones of a rat fed ethoxyquin diet, which died after
557 days, and the pair-fed control rat were dissected out and
freed from muscles and tendons. Bones were put over a Kodak 
X-ray film x 6§" and the film exposed as follows:-
Tube voltage - 60 KV (Kilo-volt)
Tube current - 50 mA
Exposure time - 6 seconds 
Focal spot distance - 80 cm.
The film was developed in Kodak DX-80 developer for U minutes 
at 20°C. It was then put in a stop bath of 2% acetic acid 
for 10 seconds and fixed in Kodak FX-i[0. for 10 minutes * It 
was washed in running tap water and dried.
3. RESULTS
(a) Food-intake
Figure 2,1. shows the food intake of rats fed the control 
diet and the diets containing antioxidants. The animals 
that received the diet containing 0 .05% a tocopheryl acetate 
consistently ate more food than the Controls fed ad-libitum.
The animals that received the diet containing 0.5% a tocopheryl 
acetate ate a similar amount of food to the controls. The animals 
that received the diet containing 0 .5% ethoxyquin ate rather less 
than the controls for the first 1§ months of the experiment but from 
the 3rd to the 9th month the food intake of the experimental group 
matched that of controls. After 9 months the animals began to eat 
less food and they continued to do so until the last animal died.
(b) Body weight gain
The growth curves of the seven groups of rats are shown in Figure 2,2. 
The animals that received the diet containing 0.05% a-tocopheryl 
acetate grew faster than their pair-fed controls due to improved food 
utilisation.
The addition of 0.5 % a tocopheryl acetate to the diet also 
showed some improvement of food utilisation as the body weight was 
increased after about k months but the effect'was never as marked 
as at the lower level of administration. These results suggest that 
there may be some advantage from the supplementation of animal 
food-stuffs with vitamin E in respect of an increased food conversion 
ratio although it is recognised that different species may differ in their
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In rats receiving 0.5% ethoxyquin, the growth rate was 
depressed, and the animals never recovered from the initial 
impairment of growth. Comparison with pair-fed controls 
shows, however, that there was no decrease in food utilisation 
until after about 9 months when the body weight of the experimental 
group started to fall below that of the pair-fed controls and 
this trend continued to the end of the experiment. This 
probably reflects a toxic response, since subsequently four 
animals receiving ethoxyquin died with severe kidney damage.
The individual data used to compile Figures 2,1. and 2,2 
are given in Tables 2,3 and 2,^ in the Appendix.
(c) Haematology
The results of the haematological studies are shown in
Table 2,5. Both vitamin E 0.5% and ethoxyquin 0.5% in the diet
causes significant reduction in PGV and significant increase in .
circulating reticulocytes. Ethoxyquin also causes significant increase
in clotting time. Tocopheryl acetate 0.05% had no significant effect on
any of these parameters, although there was an increase in circulating
reticulocytes.
The RBC values of the vitamin E treated group were not 
significantly different from the pair-fed control. The haemoglobin 
value of the 0.5% vitamin E treated group was significantly higher 
than the pair-fed control, but in the case of the 0 .05% vitamin 
E treated group, the difference was not significant. Animals 
fed 0 .5% ethoxyquin in the diet had lower values for haemoglobin 
than pair-fed control, but there was only a small number of rats
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and they were fed for a different number of days. Similar 
studies have been done in Chapter 6, with five rats in each 
group.
(d) Urine examination
The results of the urine analysis are given in Table 2,6.
Rats given a diet containing 0.5$ vitamin E excreted less . 
creatinine in the urine than the pair-fed control.
Rats that consumed the diet containing 0.5$ ethoxyquin 
excreted more protein and sodium in the urine than the pair-fed 
control.
The volume of urine excreted by rats receiving 0.5$ vitamin 
E was less than that of rats receiving 0.5$ ethoxyquin,
(e) Histology
(i) Kidney
Photomicrographs of sections of the kidneys of rats that 
consumed the diet containing 0 .5$ ethoxyquin for ^0 7 9 ^ 5 9 ^81 
days respectively are shown in plates 2-1 AB to 2-IV AB. The 
kidneys of the ethoxyquin-treated animals show irregular zones 
of fibrosis and heavy lymphocytic infiltration due to nephritis. 
A brownish pigment was visible in the tubules of kidneys from 
ethoxyquin-treated animals, but none was visible in the kidneys 
of rats fed with the control diet. The brownish pigment was not 
haemos iderin because it did not stain with Peris7 Prussian Blue 
method for ferric ion.
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Plate 2-1 A,B Photomicrograph of kidney of rat which died after bOJ days 
of ethoxyquin in the diet (ad-lihitum) (H.E)
Photomicrograph A shows area of fibrosis (F),cells containing brown 
pigment (P) in the tubules; hyaline casts (H) (x 156)
Photomicrograph B shows pigment cells (P) in tubules at higher magnification 
(x 625).
APlate 2-II A, B Photomicrograph of kidney of rat which died after 4^5 days of 
feeding ethoxyquin in the diet ad libitum (H.E.). Photomicrograph A shows 
hyaline casts (H) in the dilated tubules (x 156). Photomicrograph B shows 
lymphocyte infiltration, pigment containing cells in the tubules (P)
(x 391).
Plate 2-III Photomicrograph of kidney of rat which died after k Q l days 
of ethoxyquin in the diet ad-libitum (A.E. x 391).
Photomicrograph shows swollen glomerulus (G), pigment cells (P) and 
hyaline casts (H).
AB
Plate - 2-IV A,B. Photomicrograph of kidney of rat killed after pair-feeding 
with control diet for b b 5 days (H.E. : x 156). Photmicrograph A shows normal 
appearance of glomerulus and kidney tubules. Photomicrograph B shows hyaline 
casts (H) in the dilated tubules; lymphocytes (L), This degenerative change is 
surrounded by normal kidney tissue (K).
Casts Gaining with eosin were present in the dilated 
tubules, thus suggesting hyaline degeneration.
(ii) Liver Comparison of the structure of the liver of the 
rat given a diet containing 0 .5$ w/w ethoxyquin for ii8l days 
(Plate 2-VB) with that of its pair-fed control (Plate 2-VA) 
shows that the cells in the central vein area have more 
cytoplasm and are therefore enlarged. This is suggestive of 
proliferation of endoplasmic reticulum due to enzyme 
induction. The nuclear size and the number of polynucleated 
cells are not increased.
(iii) Bones The femur of the rat given a diet containing 
0.5$ w/w ethoxyquin for 5 77 days (Plate 2-VI B) contained 
un-calcified zones invaded -by vascular fibro-cellular tissue 
with trabeculae of ost.eoid tissue. The bone appears to have been 
irregularly resolved and replaced by loose fibrous tissue. Rows 
of osteoblasts are scattered in the bone whilst numerous osteoclasts 
are present on the trabeculae. Enlarged spaces in the bone are 
filled with loose, abundant vascular fibrocellular tissue. The 
cells are small, spindle-shaped and include lymphocytes. None of 
these abnormalities were present in the corresponding bone of the 
pair-fed control (Plate 2-VI A). The humerus of the ethoxyquin- 
treated rat (Plate 2-VIIB) also shows spaces and an increase in 
osteoid tissue. The structure of the ulna was similar (Plate 2-VIII B).
(f) Bone radiography
The radiographs of bones of the animal fed the 0.5$ w/w ethoxyquin 
containing diet for $77 days and its pair-fed control are shown in
AB
Plate - 2-V A Photomicrograph of liver of rat killed after pair-feeding with control 
diet for 48l days. (H.E.: x 625). It shows normal liver structure. Photomicrograph B. 
is the liver of rat which died after U8l days of ethoxyquin in the diet ad-libitum 
(H.E.: x 625). Cells in the central vein area are enlarged (E).
Plate 2-VI (A) Photomicrograph of femur of rat killed after pair feeding 
with control diet for 577 days (H.E. x 156) normal histology.
(B) Photomicrograph of femur of rat which died after 577 days of 
ethoxyquin in the diet ad-libitum (H.E. x 156). Section shows areas 
of osteoid tissue (0) in bone matrix.
AB
Plate 2-VII (A) Photomicrograph of humerus of rat killed after pair feeding 
with control diet for 577 days (H.E. x 156) normal histology.
(B) Photomicrograph of humerus of rat which died after 577 days of ethoxyquin 
in the diet ad-libitum (H.E. x 156) section shows spaces(S) and increase in osteoid
tissue (0).
BPlate 2-VIII (A) Photomicrograph of ulna of rat killed after pair-feeding with 
control diet for 577 days (H.E. x 156) Normal histology.
(B) Photomicrograph of ulna of rat which died after 577 days of feeding etho quin 
in the diet ad-libitum (H.E. x 156) Section shows spaces (S) and osteoid t . ->oue.
Plates 2-IX-2 and 2-IX-l respectively. The scapula of the 
ethoxyquin treated animal was smaller and less dense on “the plate although 
the difference in thickness could not he distinguished by measurement 
with a slide caliper.
Discussion
Weight gains in both 0,05% and 0.5% vitamin E treated groups 
were greater than in controls, either pair-fed or 'fed ad-libitum.
From this criterion alone, the control diet would appear sub-optimal 
despite the absence of vitamin E deficiency symptoms. However,
McCay et al., (1939) found a negative correlation between growth 
rate and life-span, and maximum growth rate or food efficiency may 
not, therefore, necessarily be optimal for lengthening the life-span.
The early reduction in weight gain in the 0.5% ethoxyquin- 
treated group was due in part to impaired palatability and pair-fed 
controls displaying a similar growth rate. Later, however, the 
fall in the food intake and body weight correlated with the occurrence 
of nephrotoxicity. Kidney damage was observed in animals that died 
after receiving the diet containing 0.5% ethoxyquin. The kidneys were 
smaller and there was shallow pitting in the cortex. The kidney 
contained a brownish pigment which did not give the appropriate 
staining response for haemostderin and which appeared to be 
lipofuscin. Analysis of the urine of surviving animals showed that 
in spite of wide day to day variation in composition, the ethoxyquin- 
treated animals excreted more protein, creatinine, sodium and potassium, 
and this would be in agreement with the finding of pathological changes 
in the structure of the kidney of the animals,that died. The urinary
X-Ray films of the bones of the rat} left side
Plate-2-IX-l is the bones of rat hilled after jjair feeding with 
control diet for 577 days.
Plate-2-IX-2 is the bones of rat which died after 577 days of feeding 
ethoxyquin in the diet ad-libitum. Scapula (S) is smaller and less 
dense than in control.
excretion of protein and creatinine by animals 
receiving the diet containing 0,5% vitamin E was less than that 
excreted by the controls and this is suggestive of a protective 
effect on cellular membrane.
Kidney damage in rats receiving ethoxyquin at dietary levels 
in excess of 0,025% w/w has been reported previously (Wilson et al*,
1959) and confirmed in this study (Rudra et al., 197^)» but no such 
pathology was reported in mice receiving 0,5% w/w ethoxyquin where 
prolongevity was observed (Comfort et al., 1971).
The bones of one animal treated with ethoxyquin and its pair-fed 
control were examined histologically. The appearance suggested 
widespread orteoporosis with areas of bone resorption. There was 
also some uncalcified osteoid tissue present, and this suggests that 
there had been interference with normal calcification mechanisms.
Chemically, the majority of the bones examined contained a higher 
proportion of water and a correspondingly lower proportion of ash.
The antioxidants particularly ethoxyquin appeared to affect .the maturation ol 
erythrocytes for there was an increase in circulatory reticulocytes. 
In"ethoxyquin treated rat clotting time was also increased. March et al(l969)
reported that excess vitamin E (120-220 Itykg) in the diet in chickens 
caused reticulocytosis, but they found no change in the haematocrit„
They concluded that the excess vitamin E retarded the maturation of 
red blood cells. In a later paper (March et al., 1973) higher con­
centrations of vitamin E (2,200 IU/kg) in the diet of chickens 
induced reticulocytosis and caused a reduction of the haematocrit.
This low haematocrit value could be due to a limitation in red blood
cell (RBC) development or to a shortening of RBC maturation.
Prothrombin times were lengthened in these chickens treated with 
high doses of vitamin E, but were rapidly normalised by the 
administration of menaquinone. Wooley (l9*+5 ) found that the administration 
of dl-a-tocopheryl quinone to pregnant mice caused haemorrhage in the 
reproductive system and resorption of fetuses. The action of the 
quinone was prevented by small amounts of menaquinone (which is regarded 
as a structural analogue of vitamin K) but not by even larger doses 
of dl-a-tocopheryl acetate. Following an excessive intake of dl-a-toco­
pheryl acetate, sufficient quinone may: be.produced to increase the 
dietary requirement for vitamin K. These findings may suggest atoxic 
response to an excessive intake of vitamin E.
The control ad-libitum group lost body weight between 20 and 21 
months and the death of all animals in k weeks is completely unexpected.
It differs from the control pair-fed ad-libitum group. This is not 
normal ageing process but suggestive of environmental factors as infection, 
although at autopsy no gross damage to any of the major organs observed.
The fact that 1 month prior to dying high level of protein in urine suggest 
glomerular damage in kidney.
Chapter 3
Developmental pattern of lipid peroxide in the different
brain parts of rat
Introduction
Regeneration does not occur in the central nervous system and 
for this reason any changes that may occur in its structure during the 
process of ageing are likely to be permanent. A number of studies 
have been reported in the literature on the rate of loss of nerve 
cells in the brain of ageing mammals. Ellis (1921) estimated the 
number of Purkinje cells in the cerebellum of humans of various ages 
and showed a consistent decrease with age in the number of cells per 
unit area. Brody, (1955) studied the cell loss in the cerebral cortex 
of man ranging from newborn to 95 years of age and also found consistent 
loss of cells.
Lipid peroxidation in vivo has been identified as a basic 
deteriorative reaction in cellular ageing processes (Barber and Bernheim, 
1967). Lipid peroxidation is damaging because of the subsequent 
reactions of free radicals, mainly peroxy radicals R00., which are produced. 
Because of their unpaired electrons, free radicals react very 
energetically and initiate relatively non-specific, hydrogen abstraction 
and chemical addition reactions (Slater, 1972).
One concomitant of ageing in the brain, as in some other organs 
such as the heart, is the accumulation of an age-pigment, which has 
been called "Lipofuscin". This pigment has been considered to be a 
normal constituent of nerve cells (Greenfield & Meyer, 1963).
There is evidence that the amount of lipofuscin in human 
(Strehler et. al, 1959) and dog myocardium (Munnell& Getty, 1968) and in 
mouse and rat brain (Reichel et al, 1968) increases with age. It has 
been suggested that the pigment is formed as the result of autoxidation 
of polyunsaturated lipids, for it is known that these can form peroxides
in the presence of biological metal complexes and that these peroxides
propagate a chain reaction yielding malondialdehyde (Kormendy & Bender,
1971)• Malondialdehyde can either tautomerise to the less reactive
3-hydroxyacrolein (Horton & Packer, 1970) or it can interact with free
amino groups of peptides and proteins (Chio et al, 1969)9 forming
Schiff-base-protein cross links (Fig. III.l) which could have
deleterious consequences on normal cellular function.
»
Fig. III.l Products of lipid peroxidation
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(Chio et al, 1969) 
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360-390 nm 1+50-^70 nm
Lipofuscin 365
For example, it has been shown that the fluorescent emission 
wavelength of Schiff-base derivatives coincides with that of lipofuscin 
pigment.
Additional interest in the present context centres on the fact 
that there appears to be a close similarity of lipofuscin to the 
ceroid pigments. These pigments are found in the organs of vitamin E 
deficient animals where they are formed as a polymerisation product 
of polyunsaturated fatty acids (PUFA).
In view of the known and supposed involvement of free radical 
reactions and lipid peroxidation in some pathological and ageing 
processes, a greater understanding of these reactions in vivo could 
have far reaching consequences for human health.
The process of peroxidation in tissues can be studied by measuring 
the product of the chain reaction described above, namely, malondialdehyde, 
for this reacts with thiobarbituric acid (TBA) to form a chromophore, 
which can be measured quantitatively in a spectrophotometer.
The brain is of particular interest for , from what has been said, 
it seems possible that the rate of deposition of lipofuscin could be 
influenced by vitamin E or other antioxidant intake of man or experimental 
animals. Reports in the literature about the changes with age of the 
lipid peroxide content of the rat brain are, however, conflicting, for 
whilst Pritchard and Singh (1961) observed a rise to 15 d of age 
with a subsequent decrease to a lower mature value, Yoshikawa & Hirai 
(1967) reported a steady rise between one and eighteen months of age.
It has been necessary, therefore, to repeat this work in order to 
establish a baseline from which to approach our supplementation studies.
Materials and Methods
: Animals
Inbred male Wistar albino rats of different litters aged between 
1 and 27 weeks were used in these experiments and accommodated in the 
University Animal Unit where the relative humidity .(50$), temperature 
(20° - 22°C) were regulated. The light was on for a twelve hour 
cycle. They were given stock pellet diets (Spillers small animal 
diet) and water ad libitum.
Chemicals
, -,v. Thiobarbituric • acid ■ (TBA) 99% pure 'and 1,1,3 93-Tetraethoxypropane
(TEP) were obtained from BDH. All other chemicals .used were. of "Analar
grade.
Animals of 1, 2, 39 4, 8 and 27 weeks of age were killed by
decapitation, the brain dissected into 3 parts, forebrain, cerebellum 
and brain stem (Walker et al, 1973bVeighed quickly and put into 
liquid nitrogen.
Lipid peroxide was determined in the individual parts of. at 
least five brains by the thiobarbituric acid method of Bieri &
Anderson (i960) modified in that 1% homogenate in cold 0.1 M phosphate 
buffer of pH 7*4 was used instead of 9% as described by the authors, 
where the colour was too strong to measure. The results were expressed 
in terms of malondialdehyde (MDA) according to a standard curve 
prepared by the method of Sinnhuber & Yu (1958)•
Preparation of standard curve
When l,l,333“tetraethoxypropane (TEP) is used in the thiobarbituric 
acid (TBA) procedure it is hydrolysed to yield malonaldehyde (MDA) 
which reacts withTBA to give the typical pink colour. In this work 
TEP has been used as a standard for the TBA determination of MDA.
Different concentrations of TEP from 2.5 nmole - 80 nmole in 1 ml
were made with the addition of phosphate buffer, pH 7*4; 0.1 M and treated
in the same way as the brain homogenate. The optical density was 
measured in a Cecil spectrophotometer Model CE272 at 535 nm. A typical 
standard curve is shown in Fig. III.2.
Results
In the forebrain (Fig. III.3) the concentration of MDA rose 
between 1 and 2 weeks of age, and subsequently fell to a somewhat
lower mature value by 8 weeks of age. The absolute amount of MDA
per forebrain did in fact reach a mature value by 2 weeks of age.
The cerebellum (Fig. III.4) increases in weight rather more rapidly 
than the forebrain, and continues to increase in weight for.a longer 
time. In this part of the brain, the concentration of MDA rose more 
steeply between weeks 1 and 2 than in the forebrain and fell more 
sharply and steadily after 2 weeks of age. As in the forebrain, there 
was little change after 2 - 3  weeks in the absolute amount per 
cerebellum.
In the brain stem (Fig. III.5) in contrast to the other two parts, 
there was a fall in concentrations of MDA froml week through, to 27 weeks 
of age. Over this period there was, however, a rise in weight, so that
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the absolute amount of MDA per brain stem remained constant throughout 
the age period studied.
The body weight and brain parts weight of these animals 
increased steadily between the first week and twenty seventh week 
(Table III.l).
Discussion
The results described are in agreement with thos of Pritchard 
& Singh (1961). However, changes in whole brain are a reflection 
of those that occur in the bulk of the organs5and small parts 
may show a substantially different pattern. In the brain stem 
the concentration of MDA did not increase between 1 and 2 weeks of 
age but others showed a steady decline with age. This decline in 
concentrations after 2 weeks of age were also evident in the forebrain 
and brain stem.
A fall in concentration of a constituent may be due to a decrease 
in the amount present, or to a relatively greater increase in the con­
centration of other constituents. It is clear that in all three parts 
of the'brain studied here, the fall in concentration is to be attributed 
to the latter change, for the total amount per brain part showed little 
change after two weeks in the forebrain and cerebellum, and after 1 
week in the brain stem.
The differences in lipid peroxide levels in the brain may be due 
to the different level of antioxidant present in the diet and hence in 
the tissues at different ages of rat. The fact that the concentration 
of MDA in the brain stem showed a steady decline with age does not
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necessarily reflect a fall in rate of lipid peroxidation but may 
indicate an increased rate of conversion to lipofuscin or other 
reaction product e.g. hydroxyacrolein. MDA seems to be the 
precursor of lipofuscin pigment as it is one of the visible end 
products of peroxidation which can be prevented by magnesium 
orotate and Karwain (Kormendy and Bender, 1971)*
OCH, COO Mg
-0 H
Karwain Magnesium orotate
Detection and measurements of lipofuscin pigment have been discussed 
in Chapter  ^in detail.
CHAPTER k
Lipofuscin pigment accumulation in the rat brain
Introduction
Age pigments (lipofuscin) result from ageing processes and 
are known to accumulate mainly in the heart, brain and muscles of 
old animals and old people.
Marked deterioration of learning and progressive loss of 
memory are known to occur with advancing age in most species of 
animals and humans. The biological basis of this deterioration is 
not clearly understood, but it correlates with gradual accumulation 
of age pigment.
. Histochemical studies suggest that a pigment similar to 
lipofuscin is derived by peroxidation and polymerisation of unsaturated 
fats (Elftman et_ al, 19^ +9) • This pigment is similar to a yellowish 
brown, waxy pigment commonly observed in association with nutritional 
cirrhosis in rats on low protein diets and first characterised by 
(Lillie at al, 19^2) who proposed the term "ceroid". Further 
histochemical study supports the theory that ceroid arises through 
the autoxidation of unsaturated lipids and is pathologically 
accumulated in cells having an insufficiency of biological antioxidants 
(Sulkin & Srivanij, i960). However recent work (Siakotos et al, 1973) 
indicates that ceroid differs significantly from age pigment lipofuscin 
bn the basis of cation composition. Ceroid contains significantly 
higher concentrations of iron, calcium and copper suggesting that 
divalent ions may be important for the in vivo stability of this 
particulate or conversely in the case of iron and copper, these 
elements may be involved in the formation of the pigment by 
catalysis of oxidative processes. In its lipid composition 
lipofuscin contains very low concentrations of native phospholipids 
and high concentration of non-polar lipid polymer while the ceroids 
contain high concentrations of acidic lipid polymer. Lipofuscin
has been isolated from normal individuals but ceroid has never 
been isolated from normal tissues but is associated with some 
form of pathology. The two pigments cannot be distinguished 
enzymatically since both contain similar lysosomal hydrolases, 
suggesting lysosomal origin.
Electron microscopy has revealed structures varying from 
electron-dense osmiophilic particles bound within a single membrane, 
with polymorphic internal structures of fine particles in early stages 
to aggregates of coarse laminated bodies composed qf dense granular 
material in cells of old subjects (Brizzee & Johnson, 1970; Samorajski 
jet al, 196U). Release of lysosomal hydrolytic enzymes occurs during 
the ageing process causing catabolic changes in the tissues# When 
the lysosome membrane is damaged, some of it can be incorporated 
into lipofuscin age pigments. When damaged intracellular membrane 
comes into contact with lysosomes it can only be partly hydrolysed 
and then the lysosomes cannot perform their normal function.
This results in the cell being congested with material which the 
lysosome cannot metabolise leading to the formation of age pigments.
It has also been suggested that cell organelles such as mitochondria, 
Golgi bodies, and endoplasmic reticulum are responsible for the genesis 
of the lipofuscin pigment (Hasan & Glees, 1972; Toth, 1968).
The deposition of lipofuscin pigment may be modified experimentally 
by drugs, hormones, and immunoregulators and the fact that lipofuscin 
is sometimes observed in apparently healthy young animals led to the 
suggestion that the pigment may be a harmless by-product of cellular 
metabolism (Handy, 1968; Kormanday& Bender, 1 9 1 1 ) .
Pigment accumulation in the adipose tissue of rats on a diet
containing small amounts of vitamin E has been reported by Mason 
et al (19^6). In aged humans with senile dementia the fall in 
brain weight is greater than in aged humans without dementia 
(Terry, 1972). Lai et al (1973) have shown that ageing rats on 
vitamin E deficient diets showed greater loss of memory functions 
and greater decrease in brain weight when compared with rats of the 
same age on a control diet. Their data suggest that early neuronal 
events in memory functions are susceptible to deterioration by 
ageing and vitamin E deficiency in the rat. The mechanism by 
which vitamin E deficient diets resulted in deterioration of 
brain functions is not clear but accumulation of lipofuscin pigment 
in the neurons may alter their cellular metabolism and electrical 
activity. The hippocampus particularly seemed to be more affected 
by vitamin E deficiency in the rat and contained more lipofuscin 
pigment. Cellular and regional differences in the accumulation 
of lipofuscin pigment in rat and mice have been reported (Reichel 
et al, 1968). It could be that the deterioration of some sensory 
and motor functions in senescence may be a consequence of selective 
alterations in discrete regions of the brain rather than uniform 
cellular ageing throughout the nervous system. Genetic and 
environmental interactions on the rate of lipofuscin accumulation 
with age can be clarified only by controlled life span studies.
This is why the present project was undertaken.
The objective of the study was to examine the accumulation 
of lipofuscin pigment in the brain and the probability of reducing 
the rate of accumulation by long-term treatment with natural and 
synthetic antioxidants. The amount of lipofuscin pigment present
in the treated and control rat brain was quantitated by fluorescence 
microscopy of the brain sections.
Experimental Protocol
The animal protocol used was as described in Chapter 2. The 
rats treated with low and high doses of vitamin E up to 702 days 
and the longest survived ethoxyquin treated rat (577 days) with, their 
pair fed controls were killed by decapitation and the brains 
removed as quickly as possible. The brains were cut into two halves 
longitudally and put in 10% buffered neutral formalin immediately. 
The tissues were then processed as described in Chapter 2 in an 
automatic "Histokinette" machine for dehydration and clearing 
then embedded in paraffin wax. The blocks were sectioned 
longitudinally at 5y in a Rotary microtome (American Optical Co.).
Attempts were made to quantitate the lipofuscin pigment 
by fluorescence photomicrography in two ways (a) by varying the 
exposure time until the intensity of the photographic image 
matched between control and tests, (b) by microdensitometry on 
the photographic negative using the Joyce-Lobel double beam 
automatic recording microdensitometer Mk III cs.
Determination of the lipofuscin pigment by fluorescence microscopy 
and quantification by micro-densitometry
Paraffin was removed from the brain sections with xylene.
They were then put into industrialmethylated spiritfI»M.S.) and 
finally into distilled water. The sections were mounted in 
glycerol after wiping off the excess water surrounding the section
with a blotting paper. In this study lipofuscin pigment was
considered to be any intracellular granules exhibiting yellow-
orange fluorescence under ultra-violet light. Unstained
sections were examined with a Carl Zeiss universal polarising microscope
(Carl Zeiss, Oberkochen Ltd., West Germany). A polarising objective
0.85 N.A. x ^0 was used giving a total magnification of 200
(HO x 1.25 x 1(). The emission from an Osram high pressure mercury
lamp H 30 200 W, passed through a BG 3 exciting filter (approximate
wave length 320-H20, my ) and BG 38 heat absorbing filter. Two
barrier filters 50A H  were used between the sample and observer.
Several brain sections of treated and control animals were 
examined. The brightest fluorescent area of similar cells was 
chosen and photographed, exposing for 2 - HO minutes:depending on 
the intensity of the fluorescence with Ilford Pan F film in the 
camera attached to the microscope. The films were developed, 
fixed in the same way and printed. The print has been enlarged 
seven times from the negative and the total magnification in the 
print is therefore 200 x 7 - lH0 0.
Lipofuscin pigment measurement
A double beam automatic recording microdensitometer (MK III CS. 
Joyce-Lobel and Co, Ltd. , England) was used to measure the amount 
of lipofuscin pigment present in the cells of the brain sections 
of anti oxidant treated and control animals. The density of the 
photographic negatives of the fluorescent image was measured as 
an indication of the intensity and amount of lipofuscin pigment.
The principle of operation is that light from a single source is 
split into two beams; one passes through the photographic film and 
the other passes through an optical reference wedge. By a shutter 
system the beams are switched alternately to a single photo-
multiplier. If the two beams are of different intensities 
a signal is produced by the photomultiplier which, after 
amplification, causes a motor to move the reference wedge to 
reduce the intensity difference to zero. This displacement of the 
calibrated wedge indicates the extinction of the specimen, and 
is transcribed into a graph by a pen attached to the wedge. To 
measure the area of the graph an integrator is attached to the 
machine. The microdensitometer scans part of the photographic 
image of the section, producing a trace. The area under the 
trace, is then measured by the integrator. Similarly a background 
trace was made and the integrator measures the area under the 
trace.
LAMP
SHUTTER
PHOTOMULTIPLIER
REFERENCE WEDGEPHOTOGRAPHIC FILM
Recording microdensitometry 
A "C" wedge at 10 x magnification, with 1.5 neutral density filter
in the reference beam was used. The ratio was 50 : 1.
Results
A clear picture of the fluorescent lipofuscin pigment granules 
was visible in the print and film (Plates k-IA - A-IIIB). The 
distribution of the pigment was not uniform in the different parts 
of the brain, and this is in agreement with the observation of 
Reichel et al. (1968). There may not be a significant difference 
in the distribution of pigment between antioxidant treated and 
control animals but there were significant differences in 
the intensity of fluorescence. The intensity of fluorescence in 
brighter cells was less in the antioxidant treated animals particularly 
at the 0 .5$ level of the diet and this was demonstrated by the fact 
that it required 30-1*0 minutes exposure to get a good picture in 
contrast to 2~5 minutes exposure in the control animal.
Table A-l shows a comparison of the maximum fluorescent 
intensity of lipofuscin in several sections of similar regions of 
the brain of test and control animals. From these results it can 
be seen that all the antioxidant treated animals displayed a significantly 
lower intensity fluorescence, the effect being most marked in the 702 day 
old animals receiving 0 .5$ a-tocopheryl acetate.
The accumulation of lipofuscin in control animals between 5T7 
and 702 days is clearly demonstrated although ageing changes in the 
pair fed controls for the ethoxyquin treated group may have, been 
modified by caloric restriction.
Plate No. ^-1
*
m
\
A
Fluorescent photomicrograph of 0.05% Vitamin E Pair Fed Control diet for 
702 days. White areas in the picture indicate fluorescent lipofuscin 
pigment x lUOO
B
Fluorescent photomicrograph of 0.05% Vitamin E treated for 702 days x 1^00
Plate No. U-II
A
Fluorescent photomicrograph of 0 . 5 % Vitamin E Pair Fed Control diet for 
702 days. White areas in the picture indicate fluorescent lipofuscin 
pigment x llj-00.
B
Fluorescent photomicrograph of 0 . 5 % of Vitamin E treated for J 0 2 days x 1^00
Plate No. 4-III
A
Fluorescent photomicrograph of 0.5% ethoxyquin Pair Fed Control Diet for 57 J days. 
White areas in the picture indicate fluorescent lipofuscin pigment x lUOO
B
Fluorescent photomicrograph of 0.5% ethoxyquin treated for 577 days x I-tUO
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Table 4-II shows the comparison of the mean fluorescence intensity 
in the same sections, i.e. the integrated area under the densitometer 
curve divided by the length of base. Once again the results indicated 
a significant lowering of brain lipofuscin concentrations in animals 
receiving 0.5% antioxidant although the difference between test and 
controls in the case of animals receiving 0 .05% a tocopheryl acetate 
was not statistically significant. Microdensitometric tracings are 
shown in Fig. 4-1 to 4-VI in the appendix.
Discussion
From these results it is clear that antioxidants such as vitamin E 
or ethoxyquin can reduce accumulation of. lipofuscin when fed at high 
dietary levels of around 0.5%. However, there are problems of 
nephrotoxicity when ethoxyquin is administered at this level. (See 
Chapter 2, and Rudra et_ _al, 1974). On the basis of these results, there 
may be advantages in supplementing vitamin E intake at very much higher 
levels than those required to prevent frank deficiency in the rat.
Molenaar et_ al (1973) suggested that deficiency of vitamin E in man 
and animals causes changes in membrane ultrastructure which can be correlated 
with a change in chemical composition and function pointing to the membrane 
as the functional site of vitamin E. The evidence that vitamin E exerts its 
biological function in the membrane is accumulating and it has been suggested
by Diplock & Lucy (1973) that it is present as a complex with the poly­
unsaturated fatty acids of the phospholipids, a-tocopherol inhibits 
the peroxidation of membrane bound polyunsaturated fatty acids associated 
with the microsomal of mitochondrial electron transport systems 
(McCay et al, 1972).
It is reported that the nutritional status of the entire organism may pla 
an important role in determining whether or not ceroid will he deposited 
in any part of the hody. A high intake of polyunsaturated fat or a low 
intake of vitamin E will favour its formation, particularly if abnormal; 
deposits of lipid form in liver, muscle or other organs. If in addition 
there is a haemorrhage it acts as an ideal catalyst by releasing oxygen 
and hematin from the degenerating erythrocytes for the copolymerisation 
of unsaturated fat. The greater the ratio of polyunsaturated to saturated 
fat at the site of any local accumulation of lipid, and the greater the 
ratio of oxidative catalysts to tissue antioxidants at the same site, 
the more abundant will be the formation of ceroid pigment. The &bove 
idea can be expressed in the form of an equation.
Amount of ceroid = f (Ratio of Polyunsaturated fat
saturated fat
x ratio of oxidative catalysts x 
tissue antioxidant
Hartroft & Porta (1967)
Oxidative catalysts, including haemoglobin, cytochrome c, hematin compounds 
and hemin, favoured the formation of ceroid.
In view of the fact that (i) lipofuscin correlates with impairment 
brain function, (ii) drugs such as Lucidril (meclofenoxate) used in 
treating senile dementia also reduced lipofuscin in old guinea pig£
103
(Nandy, 1968) the hypothesis that supplementary vitamin E may delay age related 
loss of mental function needs closer scrutiny. While Diplock (197*0 5 
stressed the functional importance of a-tocopherol in hiological 
membranesand proposed -a structural integration with selenoprotein in 
lipid membrane, the fact that the structurally unrelated ethoxyquin also 
reduced lipofuscin accumulation in rat brain suggests that it is the 
antioxidant properties which are of most importance.
It is known that free radicals are produced by the interaction of 
a substrate (e.g. hydrogen peroxide) with a metal, ion that can
undergo univalent redox change. Mixture of ferrous ions and hydrogen 
peroxide can hydroxylate organic compounds at room temperature and 
follow the course shown below:
(Uri, 1952)
Fe2+ + H202 Fe3+ + 0H~ + OH*
Fe3+ + H202
2+ • +
^  Fe + H02 + H
Fe3+ + OH”Fe2+ + 0H#
Fe3+ + H02'
3+
Fe + HO,2
2+ +
Fe + H + 02
OH + H202 — ----  + H0*2 + H20
°2~ + H2°2  * °2 + 0H" +
The scheme is consistent with the production of oxygen during the 
decomposition reaction. The reaction is not specific for ferrous
ions and hydrogen peroxide. It may be generalised to include other
. . . 2+transition metals that undergo univalent redox change e.g. copper
as -well as hydroperoxides, peroxides. By acting as a free-radical 
scavenger ethoxyquin may terminate the chain reaction and hence 
reduce the formation of lipid derived oxidation products such as 
lipofuscin. Disturbances possibly involving homolytic reactions 
catalysed by iron arise from the treatment of iron deficiency 
anaemia in piglets. Intramuscular injection of iron-colloid is given 
to treat the anaemia; iron is bound to a high molecular weight material 
so that it is released slowly in the tissue thereby reducing its 
toxicity. Patterson et_ al, (1969) have suggested that iron injections 
were particularly toxic to piglets born to a sow deficient in 
vitamin 'E causing muscular degeneration accompanied by increasing 
concentrations of iron in muscle and increasing content of malondialdehyde. 
They suggested that lipid peroxidation of intracellular membranes including 
lysosomes is involved in the muscle degeneration. Since vitamin E 
deficiency accentuates iron toxicity it seems that intracellular 
anti-oxidant has a protective effect in the susceptible piglets.
Wilson's disease in humans is an inherited disturbance of copper 
metabolism and large amounts Of this metal are found in liver, brain and 
other tissues(Goldfischer & Moskal, 1966). Copper in low concentrations 
uncouples oxidative phosphorylation in brain, myocardium and skeletal
muscle mitochondria hut not in liver, spleen, kidney . A specific 
polypeptide has been isolated from spleen mitochondria with strong 
chelating activity for copper'which-controls copper toxicity in this 
and other tissues (Vogel & Kemper, 1966). The exact mechanism by 
which the patients with Wilsons disease accumulate copper is unknown 
but the accumulation of copper in the liver lysosomes could be 
responsible for increased autoxidation of lipid leading to excess 
accumulation of lipofuscin or ceroid pigment observed in these 
patients. Again, the effects of massive supplementation with vitamin E 
or synthetic anti-oxidants seems worthy of study in this condition.
Batten’s disease or neuronal ceroid lipofuscinosis is characterised 
by the onset of progressive mental retardation and seizures (Zeman et al, 
1970)j and the brain cells of the patients accumulate large masses 
of lipopigment (Donahue et al, 1966). Similar neuronal accumulation of 
ceroid has been observed in dogs of a genetic strain of English setters. 
Stakotos et_ al, (197*+) reported that in Battenfs disease the plasma 
level of a tocopherol is significantly higher than in normal age matched 
controls. It could be that vitamin E is tightly bound to carrier 
lipoprotein and therefore not available to membranes in tissues at the site 
of peroxidation. Alternatively, high levels of peroxide occur due to 
genetic lack of peroxidase (Armstrong et_ al, 1973) so that the 
requirement for antioxidant exceeds the higher levels of a tocopherol.
CHAPTER 5
Distribution of C etho:xyquin in the “brain parts of rats
/
Introduction
. . . .  l4Although absorption and distribution of C ethoxyquin has
been investigated previously (Wilson et; al., 1959)s no work has been 
published on its distribution in different parts of the brain of 
the rat.
This is important in relation to the accumulation of lipid 
oxidation products in the brain of ageing animals. The mechanism
whereby several synthetic antioxidants appear to substitute for
. . . Ilfvitamin E could be studied m  this way. The use of C labelled
ethoxyquin has the advantage over chemical methods in that it facilitates 
quantitative estimation of ethoxyquin and its metabolites in deter­
mining their distribution in the tissues.
Materials
llf . . . . .  72,4- C-ethoxyquin, specific activity 1.6 x 10 dpm/gm, was
. . i llf . . . .used m  Experiment A and 2,4- C ethoxyquin, specific activity
789.lf.x-10. dpm/gm, was used in Experiment B.
Hyamine 10-X hydroxide solution and p-phenetidine were obtained 
from BDH. Scintillator chemicals, such as 2,5~diphenyloxazole (PPO), 
l,4-bis-2 (lf-methyl-5-phenyloxazolyl) benzene (dimethyl P0P0P), 
"Cab-O-Sil", naphthalene and ^^C-toluene internal standard (5 .65 x
10 dpm/g) were obtained from the Packard Instrument Company. All
. . 14other chemicals used were of analytical grade. Acetone 2- C was
obtained from the Radiochemical Centre, Amersham, Bucks., England. 
Experimental
Ethoxyquin was ring-labelled in the 2 and 4 positions with C,
according to Wrinch of F. Hoffman La Roche & Company (Personal 
Communication, February, 1973) , as indicated by heavy type in the 
formula
H
A mixture of 685 mg (5 m moles) of freshly distilled
p-phenetidine, 13 mg of iodine and 580 mg (10 m moles)' of acetone
lif ' .
2- C was refluxed m  3 ml flask with a stoppered reflux condenser
sealed to it for U8 hours at 85°C in a water bath. With a little
ether the reaction mixture was put into a column of 35 g of aluminium
oxide (activity grade II) further deactivated with water. The
product, Hl6 mg, was eluted with a mixture of low boiling (B.Pt.^0 - 60
petrol-ether, 5% diethyl ether and distilled in a smallHickman-type
flask at 100°C/0,001 Torr; thus yielding 398 mg of distilled product.
The overall yield was 35$ based on acetone 2-^C.
Comparison of I.R. and NMR spectra with an authentic sample of 
redistilled ethoxyquin confirmed the identit y of the product and 
freedom from impurity.
Male Wistar rats, 21 days old, (reared in the Animal Unit of 
the University) were housed individually in all-glass Jencons 
metabolic cages (Metabowl^ Mark III, Jencons Limited, Hemel 
Hempstead, Hertfordshire, England), (Plate 5~i) for at least 214- 
hours to permit acclimatisation prior to administration of 
ethoxyquin. Food (Spi H e r  s' Small Laboratory Animals' Diet, pellet 
form) and water were given ad libitum.
Plate 5~I
Rat in Jencons metabolic cage.
Experiment A C-ethoxyquin (1.1+5 U-Ci). was given as a solution
in anti-oxidant-free arachis oil (0 .2  ml) to each of five rats by 
stomach tube. The animals were killed after 72 hours, during which 
time the pellet diet and water were available ad libitum.
Experiment B Labelled ethoxyquin was given to eight rats in the
ll+diet at a level of 1 y Ci of C ethoxyquin/15 gm powder diet 
(Spillers' Small Laboratory Animal Diet, powder form) for lU days.
The rats were then placed on pellet diet and two rats killed at 
intervals of 0 , 2l+, 1+8 and 72 hours.
Preparation of tissue for radioactivity determination
The whole brain was dissected into three parts, forebrain, 
cerebellum and brain stem, as described in Chapter 3. Tissue samples (200 
300 mg) were homogenised in a tissue homogeniser with interchange­
able P.T.F.E. pestle 2 ml capacity (Elda Scientific Appliance Limited,
6 Ekron Street, Haifa, Israel) in 1.0 ml distilled water anc^  
homogeniser was washed with 1 .0 ml and 0 .5 ml distilled water and- 
all the solutions were pooled together and the volume noted. Duplicate 
aliquots (l ml) of this homogenate were transferred to low potassium 
glass scintillation vials, 1 .0 ml of hyamine was added and the mixture 
incubated for 2k hours in an oven at 37°C. After cooling, 15 ml of 
scintillator cocktail was added (see below) and the vials thoroughly 
shaken before counting.
Liquid Scintillation Counting
All determinations were made in a Packard Tricarb Liquid Scintil­
lation Counter, Model 3320, in conjunction with a Teletype print-out. 
Radioactivity thus measured was corrected for quenching and counting
efficiencies were determined by the internal standardisation procedure, 
using ±kC toluene.
Samples dissolved in organic solvents were determined by using 
15 ml scintillation gel mixture containing 1+ g PPO, 0.2 g dimethyl P0P0P,
60 g naphthalene, 20 ml 1 ,2-ethanediol, 100 ml methanol and 1,4- 
dioxane was added to make up the volume to 1 litre. This scintillator 
has a capacity of accommodating water up to 10 %. Samples were left 
in the counter for at least 24 hours before counting to reduce 
chemi lumine s cen ce.
Results
Table 5"! shows that only a small proportion of an intragastric 
dose of ethoxyquin was present in the brain 72 hours after it's administration 
The largest proportion of the dose was, however, present in the forebrain.
This was due to the greater weight of this part of the brain for the 
specific activity was, in fact, significantly lower in the forebrain than 
in either cerebellum or brain stem.
At zero time, after withdrawal of ethoxyquin, the specific activity 
was similar in the brain stem and cerebellum and lower in the forebrain 
(Table 5”II)• At 72 hours after withdrawal, the relationship of the 
activities in the different-.,parts were similar and the actual values were 
only slightly lower.
The total amount of ethoxyquin in each part also varied with time, 
as shown in Table ^ - I I T .  This is in agreement with Wilson et'_al, (1959)» 
who found a similar result with the whole brain of the rat. One of the 
animals in the 48 hour experiment was sick and its body weight was very 
low, so possibly the amount of adipose tissue was reduced, thereby
Table 5-1 Effect of intragastric administration of C ethoxyquin
in the rat on its distribution in the brain.
Specific activity 
(dpm/g tissue)
Total activity 
(dpm/part)
Percentage of 
dose t- 
x 10 P
Cerebellum
(1 )
l66+ i 2.3
4-4-4-
39.6 " 9 ± 0.9 124 9 ±4.4
Brain Stem 
(2 )
177++± 5.4 49.6t++± 1 .8 6 156+++± k .k
Fore Brain 
(3)
135 ± 7.1 l4l ± 6 .5 424 ± 18.9
Values given are means + SEM
Statistical significance of differences between values for cerbellum
and those for brain stem shown when P <0.002 and when P < 0.001
• • "f"and between cerebellum and brain stem and forebram shown when P <0 .0 1
++ +++
when P < 0.002 and when P < 0.001.
Ethoxyquin (1.45 yCi) given by stomach tube to each of 5 male 
Wister albino rats which were maintained on pellet diets for 72 hours 
and killed.
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increasing the concentration of ethoxyquin. Therefore, in the 
1*8 hour experiment the result could he an artifact. Only a small amount 
of 'ethoxyquin crossed BBB but the small amount of activity observed in the 
brain cleared very slowly . This agrees with the slow rate of turnover 
of the hulk of brain lipids.
Discussion
Drug action on the cells of the central nervous system (CNS) 
depends on the presence of the drug in the extracellular fluid (EOF) of the 
CNS. Distribution of the drugs in the ECF of the CNS depends on several 
factors. When taken orally, it must resist inactivating degradation;.in the 
lumsn of the gut, where pH is subject to variation.After, absorption through 
the intestinal wall it must pass the liver and further resist degradation 
by enzymes in the plasma and other organs. It should remain unionised 
in solution because ionisation greatly influences penetration of the 
biood-brain barrier (BBB) by making it more hydrophilic and lipophobic 
and thus favouring retention by the water phase. Lipid insoluble drugs 
have restricted distribution across BBB.
Trans location of drug from blood plasma to inner plasma membrane 
depends on its affinity for plasma proteins, water and membrane lipid.
If strongly bound to plasma protein, it is very difficult for the drug 
to escape into luminal membrane. BBB is not an impermeable barrier, 
but is selectively permeable so that exchanges take place between CNS, 
and the general ECF. In addition to BBB, brain concentration of a 
drug after systemic administration will be affected by injection on 
site, accumulation in the kidney, liver or other tissue, rate of 
systemic degradation, and the degree of brain tissue binding of the 
drug (Oldendorf, 197*0.
Rajaram et al, (197*+) have suggested that in the rat vitamin E 
is transported by serum very low density lipoproteins (VLDL) to various 
tissues. It is probable that ethoxyquin is also transported by serum 
lipoproteins to various tissues, but evidence seems at present to be 
lacking about this.
The observation that only small amounts of ethoxyquin were present 
in the brain of the rat agrees with that of Wiss ert al, (1962), who found 
that the concentration of ethoxyquin was high in the liver and kidney
but low in the brain of the rat. It appears, therefore, that the blood
brain barrier played a major part in the distribution of ethoxyquin,
largely excluding it from the brain.
. IVA small amount of vitamin E given as C dl a~tocophe.ryl acetate 
reaches the brain of the rat (Wiss et al.:, 1962) but most ■■ 
likely it becomes incorporated into the structure of the brain cells.
It seems that ethoxyquin and vitamin E can pass the blood brain 
barrier in small amounts, and that these small amounts are. sufficient 
to stop free radical formation produced during lipid peroxidation, 
thereby preventing the accumulation of lipofuscin pigment. This is 
discussed in detail in Chapter *+.
ill .
The observation that, after a single oral dose of C-ethoxyqum, the 
specific activity was higher after 1+8 hours than either 2k hours or 
72 hours is consistent with Wilson et_ al, (1959)-who made a similar 
observation but did not comment on it. Such an increase followed by 
a fall in specific activity can be accounted for if one assumes that the 
second peak of activity at *+8 hours arises from a metabolite of ethoxyquin 
which accumulates preferentially in the brain compared with other organs.
CHAPTER 6
Short term study of the effects of ethoxyquin and 
of two levels of dietary supplementation with vitamin E.
Introduction
In view of the pathological changes observed when ethoxyquin 
was fed to rats at a level of 0.5% in the diet for periods in excess 
of 9 months, further more detailed studies on the relative biological 
effects of this anti oxidant and vitamin-.E seemed warranted. In 
particular changes occurring prior to any frank manifestation of 
ethoxyquin toxicity were of interest.
Materials and Methods
Weanling rats of a similar strain to those used in the previous 
study (Chapter 2), were kept in similar environmental conditions, 
and fed similar diets. Observations of food intake and body weight 
gain were made. At the end of the experimental period, when the 
rats were 80 days of age, similar haematological examinations were 
made, and also similar analyses of urine, and histological examination 
of kidney, liver and bone. In addition, organs were weighed and the 
concentrations of vitamins A and E, total lipid, phospholipid and 
cholesterol determined in the serum and of vitamin A in the liver,
(i) Determination of vitamins E and A in serum
The concentration of free vitamin E and total vitamin A in 
serum of the rats was estimated according to the method of Hansen 
& Warwick (1969). This fluorimetric micromethod enables the 
simultaneous determination of vitamin E and vitamin A in the same 
serum sample after extraction of the vitamins in hexane. The 
procedure is extremely sensitive and the interfering compounds present
normally in the serum, such as cholesterol and carotene, do not 
interfere with the measurement.
Equipment used: A Perkin Elmer MFE-3 fluorimeter was used which was
fitted with a recorder. All glassware was boiled in 50% concentrated 
nitric acid, rinsed in tap waterj boiled in distilled water and rinsed 
again in distilled water. The quartz cuvettes were washed in the 
same way. Rubber or cork stoppers were not used.
Chemicals: Ethanol - one litre of absolute ethanol was distilled at
about 80°C over 20 gm of potassium hydroxide pellets. The first 
25 ml of the distillate and the last 100 ml of ethanol left in the 
boiler were discarded.
•Hexane'- spectroscopic grade, B.D.H. Ltd.
Water - Double distilled from all glass apparatus.
Potassium hydroxide - Analar grade, B.D.H. Ltd.
Vitamin E standard - D-a-tocopherol-Type-I was obtained from Sigma, 
England. A working standard of 0.125 yM per ml of D-a-tocopherol 
in distilled ethanol was used.
Vitamin A standard- Retinyl acetate crystalline Type-I was obtained 
from Sigma, England. A working standard of 0.821 yg per ml. of vitamin 
A acetate in distilled ethanol was used.
A standard curve containing known amounts (0.007 - 0.15 yM/ml) 
of D-a-tocopherol in ethanol was prepared and was run as described 
in the following procedure. The percentage recovery of free vitamin E 
from serum was determined by adding known amounts of D-a-tocopherol 
to 0.2 ml serum before analysis. Similarly a standard curve containing 
known amounts (0 .05-1 .2 3 yg/ml) of retinyl acetate in ethanol was 
prepared and was run as described in the following procedure. The
percentage recovery of serum total vitamin A was determined by 
adding known amounts of retinyl acetate to 0.2 ml serum before 
analysis.
Method: Distilled ethanol (2 ml) was added to each tube and
mixed on a vortex mixer for 30 seconds;  ^ml of hexane was then 
added to all tubes. They were capped and mixed for 30 seconds.
The tubes were then centrifuged in a Mistral 6L centrifuge at 
1000 RPM for 10 minutes. A portion of the top clear organic 
phase containing the extracted vitamin E was removed with a 
disposable pipette and placed in the cuvette. The standard vitamin 
E solution was scanned in the fluorimeter to determine the excitation 
and emission wavelengths of the-solution. These were found to be 
297 nm for excitation and 322 nm for emission. These were 
slightly different from the value of 295 nm and 3*+0 nm reported by Hansen 
and Warwick (1969). As suggested by Duggan (1959) the minor
differences in absorption maxima/of pure compounds can result from 
the differences of resolution in different spectrofluorimeters.
Using these operating conditions, the emission of" the'blank and the 
samples was read in the fluorimeter. The readings represent free 
yitamin E in the sample.
The technique for vitamin A assay in the samples was similar 
to that for the determination of vitamin E except that the excitation 
wavelength was 3**2 nm and the emission wavelength was *+70 nm. The 
standard vitamin A sample, blank and experimental samples were read 
at the above wavelengths for the vitamin A determination. The 
readings represent total vitamin A in the sample.
A standard curve for vitamin E is shown in Fig. 6,1. and that for
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vitamin A in Fig. 6,2.
The percentage recovery of vitamin E from serum is shown in 
Table 6,1. and that of vitamin A in Table 6,2. The mean recovery 
of vitamin E was 99.6% and that for vitamin A 92%.
(ii) Determination of total lipid in serum
Reagents: Bloor’s mixture - 1 volume of diethyl ether was mixed
with 3 volumes of ethyl alcohol. 
l-i+-p-Dioxan-BDH Ltd.
Sulphuric acid (analar) BDH Ltd. iiO ml. of concentrated sulphuric 
acid was diluted with distilled water to 1 litre.
Procedure: The method described by Huerga et al., (1953) was used.
In a graduated test tube 0.2 ml serum was taken and 3.8 ml of Bloor's 
mixture added. The tube was kept in a water bath at 60°C for 
30 minutes. After cooling to room temperature, the volume was 
restored to ^ ml with Bloor’s mixture and the tube centrifuged 
in a Mistral 6L centrifuge at 1000 rpm for 5 minutes. Aliquots of 1 ini 
of the clear supernatant were taken in duplicate in 2 tubes and 
evaporated to dryness in a boiling water bath. Thereafter 1.5 ml of 
p-Dioxan was added and the tube placed in the boiling water bath for 
1 minute, cooled to room temperature and 5 ml of sulphuric acid solution 
added. After 30 minutes the turbidity was measured in a Cecil linear 
read-out spectrophotometer at 650 nm.
Preparation of standard curve: A standard curve for the turbidity
method was prepared by extracting the lipid from rat serum with 
Bloor's solvent and evaporating the solvent. Solutions of known 
concentrations (50 yg - 1300 yg) of lipid in dioxan were then prepared 
and subjected to the turbidimetric procedure described above.
A standard curve for serum total lipid is shown in Fig. 6,3.
(iii) Determination of serum phospholipid
Proteins were precipitated with trichloroacetic acid (TCA) and 
the precipitate containing the phospholipids, was digested with 
sulphuric acid - perchloric acid reagent. The inorganic phosphorous 
was determined and by multiplying by 2 5 » the phospholipid was 
calculated.
Reagents: Trichloroacetic acid (B.D.H. Ltd.) 5% (w/v) in water.
Digestion mixture -.50.ml. distilled water, 25 ml. concentrated 
sulphuric acid .and 25 ml 70$ perchloric acid (B.D.H. Ltd.).
Sodium acetate trihydrate (B.D.H. Ltd.) 50$ (w/v) in water.
Ammonium molybdate (BDH Ltd.) 2.5$ solution in water.
Metd. (p-methylaminophenol sulphate,(B.D.H. Ltd.), 1 gm in 100 ml 
3$ sodium hydrogen sulphite (B.D.H. Ltd.).
A stock standard solution containing 1 mg P per ml. was prepared by 
dissolving V.39^ gm anhydrous potassium dihydrogen phosphate (B.D.H.) 
in one litre of solution containing 2 ml. concentrated sulphuric
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A working standard was prepared by diluting the stock standard 
1 to 100 i.e. 1 ml = 10 yg P.
Procedure: The method of Connerty et al., (l96l) was used.
In a test tube 0.2 ml of rat serum was taken and 5 ml 5$ TCA 
added slowly while shaking the tube. The tube was centrifuged at 
1000 r.p.m. for 10 minutes in Mistral 6L centrifuge to give 
a tightly packed precipitate. The supernatant was decanted off and the 
tube inverted on filter paper after wiping the inside of the rim.
Digestion mixture, 1 ml, was added and the tubes heated gently until 
the liquid became colourless. After cooling the tube, 1 ml distilled water 
was added and the contents boiled for 15 seconds to convert pyrophosphate 
to orthophosphate. Sodium acetate, 1ml (of 50$ solution) was added and 
the total volume made to 10 ml with water. Then 1 ml. ammonium 
molybdate and 1 ml metol were added and mixed well. After 15 minutes 
the absorbance was read in a Cecil linear-read-out spectrophotometer at 
700 nm against a reagent blank prepared by mixing 0 .2 5 ml 'concentrated 
sulphuric acid, 1 ml 50$ sodium acetate, 1 ml. of ammonium molybdate,
1 ml. metol and 8.75 ml distilled water. To 5 ml of working standard,
0 .2 5 ml concentrated sulphuric acid, 1ml. acetate, lml molybdate, 1 ml 
metol and 3 .75 ml distilled water were added and the absorbance read as 
above.
(iv) Determination of serum total cholesterol (Hanel & Dam, 1955)
Reagents: Glacial acetic acid, acetyl chloride, zinc chloride,anhydrous
sticks and chloroform were all of analar grade and obtained from B.D.H. 
Absolute alcohol - James Burrough Ltd. ■
Aqueous K0H solution 33$, aliquot of 50 ml 33$ aqueous K0H taken and
50 ml absolute .alcohol added to form ethanolic KOH for hydrolysis.
Zinc chloride solution AO g was crushed and mixed with 153 ml glacial aceti 
acid in a stoppered bottle and kept at 80°C for 2 \ hours. The solution 
was cooled and filtered through a glass sinter funnel.
Procedure: In a test tube, 0.2 ml serum was taken and 1 ml of
ethanolic KOH added for hydrolysis. The mixture was heated for 1 hour 
in a water bath at 50°G after putting a glass ball over the flask.
After cooling to room temperature, each sample was extracted 3 times with 
3 ml of petroleum ether {(b.p. 80 - 100). All the. extracts, 
were combined and made to a known volume. A measured volume of the 
sample was pipetted into 10 ml graduated stoppered tubes and 
evaporated to dryness. The residue was dissolved in 2 ml. chloroform 
and 1 ml. zinc chloride and 1 ml acetyl chloride added. After mixing, 
the tubes were placed in a water bath at 65°C for exactly 15 minutes.
The tubes were cooled and made up to 5 ml. with chloroform, mixed 
and the absorption read at 528 nm in a Cecil linear-read-out 
spectrophotometer. Standard solutions containing 10 pg - 80 pg 
cholesterol in chloroform were processed in the same way as the test 
samples using 2 ml. chloroform as blank. The standard curve was linear.
(v) Determination of liver vitamin A (Ames et al., 195^)
Reagents: Anhydrous sodium sulphate, chloroform, acetic anhydride
and saturated antimony trichloride solution were obtained from B.D.H. 
Vitamin A acetate was obtained from Sigma, England.
Procedure: To about 1.5 gm of liver tissue, 5 g anhydrous sodium
sulphate was added and ground in a mortar until completely dry. Then 
10 ml chloroform was added and the mixture filtered through Whatman 
No. 1 filter paper into a 50 ml volumetric flask. The chloroform
washing was repeated 3 times and the volume made up to 50 nil with 
chloroform. An aliquot of 0.1 ml of the extract was taken and 
made up to 1 ml with chloroform, 1 drop of acetic anhydride and 
3 ml of saturated antimony trichloride were added. After mixing, 
the absorbance was read immediately at 620 nm in a Cecil 
spectrophotometer. Known amounts of vitamin A standards (vitamin A 
acetate in chloroform) solutions containing 2 yg - 10 yg were run 
in the same manner as the test samples.
Standard curve for the determination of vitamin A is shown in 
Fig. 6 , k .
(vi) Determination of calcium in serum and urine (Trudeau & Freier,1967)
Principle Serum and urine specimens are diluted in a solution 
of lanthanum chloride, and aspirated into the atomic absorption 
spectrophotometer. Lanthanum competes with calcium for phosphate 
and dilution in this reagent effectively removes interference from 
phosphate and protein.
Reagents
Diluent 0.1$ w/v lanthanum as lanthanum chloride solution.
Lanthanum solution 10$ w/v (B.D.H. Lanthanum chloride solution for 
Atomic Absorption Spectroscopy) 10 ml was diluted to 1 litre with 
distilled water.
Stock Standard Analar calcium carbonate was dried and kept in a 
desiccator. A standard solution of the salt was prepared containing 
2^9*72 mg per 100 ml. This was dissolved in IN HC1 and the volume 
made to 100 ml with water in a volumetric flask.
Working standards The stock standard solution was diluted
with distilled water in acid washed 5'-nil volumetric flasks up to the 
mark as follows:
Calcium concentration mg/100 ml
6
8 '
9 7 :.
10 
11
. 12 ■
'■ 20 ■
Method
The standards and samples were diluted 1 : 50 with lanthanum 
dilueht in duplicate in disposable plastic tubes, i.e. 0 .0 5 ml of 
serum or urine sample was taken and 2 .5 ml diluent lanthanum chloride 
added in order to make a 1 : 50 dilution. Samples were mixed thoroughly 
on a whirli-mixerv Using the settings given in Table 6,3, the baseline 
on the recorder was set with the 6 mg/100 ml standard. Standards 
and test samples were aspirated into the Perkin Elmer 303 Atomic 
Absorption Spectrophotometer and the readings recorded. To correct 
the drift the 10 mg/100 ml standard was used every 6 tests. The 
standards were read again at the end. A standard curve for calcium 
is shown in Fig. 6.5.
ml. stock standard
0.30
0.35
0.40
0.45
0 .5 0
0.55
0 .6 0
1.00
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(vii) Determination of calcium in bone
The principle, diluent, stock and working standards were similar 
to those used for the determination of calcium in serum and urine.
Method
A small piece of hone (Humerus) approximately 70 mg was weighed 
accurately in an empty dry crucible. It was then dried in an oven 
at 37°C for 1+8 hours and weighed again to obtain the dry weight of 
the bone. The dry bone was ashed in the muffle furnace at 600°C for 
2k hours, and the ash dissolved in IN HC1 and made up to a volume 
of 10 ml. From this solution 0.1 ml was taken and again made up to 
1 ml with 1 N HC1 (l : 10 dilution). From here onwards the method 
was similar to that described for serum and urine calcium determination.
3. Results
(i) Food-intake
Figure 6 ,6 shows the food intake of rats fed the control diet 
and those of the animals fed the diets containing the antioxidants.
The animals that received the diet containing 0.5% a-tocopherol 
acetate ate more food than the controls fed ad-libitum,
whereas..the animals that received the diet containing 0 .05% 
a-tocopherol acetate ate a similar amount of food to the controls.
The animals that received the diet containing 0.5% ethoxyquin ate 
rather less than the controls throughout the experimental period.
(ii) Growth curves
The growth curves of the six groups of rats are shown in Figure 
6,7. The animals that received the diet containing 0,5 % 
a-tocopheryl acetate gained more weight than the controls fed ad-libitum 
and this suggests that food utilisation was improved. The addition 
of 0.05% a-tocopheryl acetate to the diet increased body weight gain 
above that of the pair-fed controls but very similar body weight to 
that of controls allowed access to food ad-libitum. These results 
suggest that there may be some advantage from the supplementation 
of animal foodstuffs with vitamin E. The food intake of the rats 
receiving the diet containing 0.5% ethoxyquin was depressed and this 
resulted in a slower growth rate from which the animals never recovered. 
There was, however, no evidence of impaired food utilisation because 
the growth rate was similar to that of the pair-fed controls. The 
growth of both these groups was less than that of the controls fed 
ad-libitum. The individual data used to compile Figs. 6,6 and 6,7 
are given in Table in the appendix.
(iii) Haematology
The results of the haematological studies are shown in Table 6,5. 
The clotting time in rats treated with antioxidants was higher than in 
the pair-fed controls, but the difference only reached statistical 
significance inthose given the diet containing 0.5% vitamin E. The 
blood of the animals receiving diets containing 0.05% vitamin E and 
0.5% ethoxyquin contained significantly more reticulocytes than that 
of their pair-fed controls. In the case of the 0.5% vitamin E treated 
group there were no such significant differences.
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Table 6,9 The serum free vitamin E and total vitamin A (mg/lOOml) of rats 
fed diets containing different concentrations of tocopheryl 
acetate or of ethoxyquin for 60 days. Values given are means 
i SEM of determinations on five rats.
Supplementation Free vitamin E Total vitamin A
0.05% DL-ot-tocopheryl 
ad-lib.
3.959± 0 .17V  
■ *
0.053 ± 0.005 
NS
Nil. Pair-fed 
control with 0 .05% 
vitamin E
0*855 ± 0 .10V . 0 .05lf ± 0 .0 0 6
0 .5% ethoxyquin 
ad-lib.
3 .293 ± 0 .208  
*
0 .1 0 1 ± 0 .0 1 0  
*
Nil. Pair-fed 
Control with 0.5% 
ethoxyquin
1 .108 ± 0 .083 0 .021 ± 0 .0 0 2
r*
0 .5% DL-a-tocopheryl
acetate
ad-lib.
7 .162 ± 0 .218
* ■■■■■■■.
0 .0 3 1 ± 0 .0 0 1  
*
Nil. Control 
ad-libitum
1 .MU+ ± 0.0i+3 0.01+3 ± 0 .0 0 2
Comparisons made between test and pair-fed controls,-in the case of animals 
receiving diets containing 0 .5% ethoxyquin and 0 .05% tocopheryl acetate 
respectively. In the case of the groups receiving the diet containing 
0.5% vitamin E the test group was compared with the control group fed 
ad-libitum. Significance of differences shown * when P < 0.001; and 
NS when not significant.
Table 6,10. The total lipid, phospholipid and cholesterol concentrations 
(mg/100 ml) in the serum of rats fed diets containing 
different concentrations of tocopheryl acetate or of ethoxyquin 
for 60 days...
Values given are means £ SEM of determinations on five rats.
Supplementation Total lipid Phospholipid Cholesterol
0.05% DL-a-toco- 
pheryl acetate 
ad-lib.
1002 ± 5 7  
NS
2kS ± 9
NS
73 ± .V
NS
Nil. Pair-fed 
control with 0 .05% 
vitamin E
I J b  ± 1 2 6 209 ± 15 69 ± b
0 .5% ethoxyquin 866 ± 3 -^ 2 6 1 + 7 107 ± 2
ad-lib. * ***
Nil. Pair-fed 
control with 0 .5$ 
ethoxyquin
6oh + 52 190 ± 8 57 ± 3
0.5% DL-a-toco- 
pheryl acetate 
ad-lib.
9b6 ± 1+3 236 ± 6 
*
81+ ± 3  
NS
Nil.
Control
ad-lib.
■
1106 ± 32 266 ± 6 82 ± 3
Comparisons made between test and pair fed controls in the case of animals 
receiving diets containing 0.5% ethoxyquin and 0 .05% tocopheryl acetate 
respectively. In the case of the groups receiving the diet containing 
0.5% vitamin E the test group was compared with the control group fed 
ad-libitum. Significance of differences shown * when P < 0.01; ** when P 
< 0.02; *** when P <0.001 and NS when not significant.
Table 6,11 The liver vitamin A (mg) of rats fed diets containing different
concentrations of tocopheryl acetate or of ethoxyquin for 60 days.
Values are given as means ± SEM of determinations on five rats.
Supplementation Vitamin A/g liver Vitamin A/ liver
0.05% DL-a-toco- 
pheryl acetate 
ad-lib.
0.930 ± 0.01+3 
*
12.77V ±0.835  
*
Nil. Pair-fed 
control with 0 . 05$ 
vitamin E
1.101  ± 0.052 15.1+10 ± 0.833
0 . 5$ ethoxyquin 
ad-lib.
0.801  ± 0 .01+2 
a
12.1+79 ± 0.686  
NS •
Nil. Pair-fed 
control with 0 . 5$ 
ethoxyquin
0 . 961+ ± o.oi+i 11.308 ± 0.582
0.5$ DL-cf-toco- 
pheryl acetate
ad-lib.
0.893  ± 0.077
NS
11.016  ±1 .159  
NS
Nil. Pair-fed 
control with 0.5$ 
vitamin E
O.98I  ± 0.035 11.982  ± 0 . 1+86
Comparisons made between test and pair-fed controls. Significance of 
differences shown * when P < 0.05; and NS when not significant.
The Packed cell volume was significantly higher than that 
of the pair-fed controls only in the 0.5$ vitamin E treated group. 
Haemoglobin and RBC values were very simlar in the antioxidant 
treated and pair-fed controls.
(iv) Urine analysis
The results of the urine analysis are shown in Table 6 ,6 . 
Important points of difference between the 0.05$ vitamin E treated 
and pair-fed control groups were 2k hour urine volume and water 
consumption, which were significantly low in the treated group.
Sodium excretion in 2k hour urine was low on the second day which 
was statistically significant in comparison with pair-fed control 
group but not significant in first day urine collections.
• • • •Sodium, potassium, protein and creatinine values of the 0 . >
vitamin E treated group was not significantly different from the 
pair-fed controls. Creatinine, and potassium excretion values in 
2k hour first day urine of 0 .5$ ethoxyquin treated group were 
significantly low in comparison with pair-fed control group but the 
values were not significant in second days urine collection. Sodium 
excretion values were not significant in Comparison with ethoxyquin 
treated and pair-fed controls. The urinary calcium of the ethoxyquin 
treated group was significantly lower than pair-fed controls.
Protein excretion values in 2k hour urine of antioxidant treated 
and pair-fed control groups were not different. The urine 
examination results varied from day to day and between 
different groups that it was difficult to reach a definite conclusion.
(v) Organ weights
The organ weights of rats fed their respective diets are shown 
in Table 6,7* The weights of the livers and kidneys of animals 
fed the 0 .5$ ethoxyquin diet were significantly higher than those 
of their pair-fed controls, otherwise, the feeding of the antioxidants 
made no difference to the weights of the organs examined.
(vi) Calcium in serum and bone (humerus)
The results of the determination of calcium in serum and bone 
are shown in Table 6 ,8 . There was no difference in the concentration 
of calcium in the serum of the ethoxyquin treated and the pair-fed 
control groups.
The humerus of the ethoxyquin-treated rats weighed less than 
that of the pair-fed control. It also contained a lower concentration 
of water and on both a wet and dry basis contained a lower concentration 
of calcium. The ash per unit weight of dry bone was not significantly 
different.
(vii) Vitamin E and vitamin A in serum
The concentration of free vitamin E and total vitamin A in the 
serum of rats fed the different diets are shown in Table 6,9- The 
concentration of free vitamin E in the serum was significantly 
higher than respective control values in the 0 .5$ and 0 .05$ vitamin 
E treated groups.
The serum of the animals receiving the diet containing 0.5% 
ethoxyquin also contained higher concentrations of free vitamin E 
levels in comparison with pair-fed controls and this suggests that 
the antioxidant had a vitamin E-sparing effect.
The concentration of total vitamin A in the serum of the 
animals receiving the diet containing 0.5$ vitamin E was significantly 
lower and that of the animals receiving the diet containing 0 .5$ 
ethoxyquin was significantly higher than in the control groups, but 
there was no difference in the concentration of vitamin A in the serum 
of 0.05$ vitamin E-treated animals and that of the pair-fed controls.
(viii) Total lipid, phospholipid and cholesterol concentration in 
serum.
Serum total lipid, phospholipid and cholesterol results are 
shown in Table 6,10. The concentration of the lipids was significantly 
higher in the 0 .5$ ethoxyquin-treated group than in the pair-fed 
controls# whereas in the animals receiving the diet containing 0 .5$ 
vitamin E the serum total lipid and phospholipid concentrations were 
significantly lowered, relative to controls fed ad-libitum. The serum ; 
cholesterol levels were similar in these two groups.
Feeding a diet containing 0.05$ vitamin E made no difference to the 
serum concentrations of the lipids examined.
(ix) Vitamin A in the liver
The livers of the animals fed the diet containing 0.05$ vitamin 
E contained a lower concentration of vitamin A and a lower total
vitamin A per liver than the pair-fed controls (Table 6,11). In the 
0.5% ethoxyquin treated group the concentration of vitamin A was 
significantly lower than in the pair-fed control group, but there was 
no change in total vitamin A value in the whole liver.
The animals that received the diet containing 0.5% vitamin E, 
showed a lower concentration of vitamin A in liver than the controls 
fed ad-libitum although the difference was not statistically 
significant. There was no change in vitamin A value in the whole 
liver between this vitamin E treated group and control.
(x) Histology of kidney, liver and bone
The procedures used have been described in Chapter 2.
a) Kidney
The kidneys of rats that consumed the diet containing 0.5% 
ethoxyquin for two months showed an increase of cytoplasm in the 
cells of the tubules compared with the pair-fed control group.
Hyaline casts, pigment, fibrosis and lymphocytes were not found.
The histology of the kidney did not show great signs of nephrotoxicity 
as observed in the long term study described in Chapter 2.
No abnormalities were found in the kidneys of animals receiving 
diets containing 0.5% and 0.05 % of vitamin E.
b) Liver
Comparison of the structure of the liver of the rat given a 
diet containing 0 .5% w/w ethoxyquin for two months with that of its 
pair-fed control showed hypertrophy of the cells in the central vein 
area.
As with the kidney, no abnormalities were found in the livers 
of animals receiving diets containing 0.5% and 0.05% vitamin E.
c) Bone
The humerus of the rat given a diet containing 0.5% w/w 
ethoxyquin for two months showed irregular un-calcified zones 
of osteoid tissue in the cortex. These were not visible in the 
controls.
Discussion
The weight gain in the 0.5% vitamin E treated group was 
greater than in controls fed ad-libitum and this suggests a 
sub-optimal level of this vitamin in the control diet as discussed 
in Chapter 2. Conversely, weight gain and food intake in the 0.5% 
ethoxyquin treated group was significantly lower than in the control 
group fed ad-libitum.
In this short-term study, the kidney histology of rats given 
0 .5% ethoxyquin in the diet did not show significant changes indicative 
of nephrotoxicity as described in Chapter 2.
The urinary excretion of sodium,' potassium, protein and creatinine 
of the 0 .5% ethoxyquin treated group were similar to those of the 
pair-fed control group suggesting normal function of the kidney. Thus, 
it appears that two months feeding of 0 .5% w/w ethxyquin in the diet 
was not long enough to produce severe nephrotoxicity.
There were, however, some changes in the liver and bone histology 
in the 0.5% ethoxyquin treated group. Chemical determination showed 
low bone calcium values, and the effects on bone are observed more 
rapidly than the nephrotoxic effects.
The liver and kidney weight of the ethoxyquin treated group were 
significantly higher than in the pair-fed control group, this is in 
agreement with the study of Wilson et al., (1959) and is suggestive 
of enzyme induction. The weight of the humerus of the ethoxyquin 
treated group was significantly lower than the pair-fed controls suggesting 
slow development of a toxic effect.
Antioxidant ingestion for 60 days caused similar increases 
in the number of circulating reticulocytes and clotting time to 
those described in the long term study (Chapter 2 ), and these could 
have been due to retarded maturation of red cells or to a lack of 
vitamin K respectively.
A diet containing either 0.05% of vitamin E or 0.5% of vitamin E 
or 0.5% of ethoxyquin resulted in levels of serum vitamin E that ..were 
high in comparison with the controls. The levels of vitamin A in the serum 
were also high in the rats receiving diets containing 0.5% vitamin E or 
0 .5% ethoxyquin, but not in those receiving the diet containing 0 .05% 
vitamin E. This suggests that the extra amounts of antioxidant in 
the diet have a protective or sparing action on the vitamin A in the 
serum.
The concentrations of vitamin A in the liver were, however, lower 
in the antioxidant treated groups than in the controls, and this together 
with the elevated Serum values suggests that the antioxidant in some way 
facilitated the removal or reduced the storage of vitamin A in the liver.
It has teen reported that ethoxyquin protects against loss of 
vitamin A in vivo in growing chicks (Gordon & Machlin, 1959) and 
turkeys (Atkinson et_ al. 9 1963) and it can cure some vitamin E 
deficiency diseases such as encephalomalacia (Matters on erfc al.,
1957; Ames & Swanson, 1958)9 exudative diathesis and muscular 
degeneration in chicks (Machlin & Gordon, 1962) by sparing vitamin 
E. ' .
Small amounts of a-tocopherol in the rat enhanced carote.ne 
utilization but larger doses markedly reduced the amount of vitamin 
A formed and stored in the liver (Johnson & Baumann, 19^ +8; Swick 
& Baumann 1951) which is in agreement with this study.
The present study has shown changes in lipid composition 
of serum of antioxidant treated groups in contrast to pair-fed 
controls. Lipids such as cholesterol and phospholipids are important 
constituents of the red blood cell membrane (Reed et_ al., i960) and 
are constantly being incorporated from the plasma into the RBC 
membrane (Reed et_ al., 1968) The vitamin E in red cells 
is localised in the membrane and rapid exchange of vitamin E takes 
place between red cells and blood plasma (Silber et al», 196 9).
Chapter 7
General Discussion
Microbial species which reproduce by simple cell division 
appear to be, to all intents and purposes,immortal, but the 
evolution of more complex organisms has led to such organisms 
having a species-specific mean lifespan. Variations about this 
mean are usually relatively small, and it is highly improbable 
that an individual will survive several times the specific 
period. As the specific lifespan varies widely between species, 
it appears that it may be genetically determined And carry 
evolutionary advantages. No single primary mechanism of ageing 
has emerged, however, to account for all the slow, degenerative 
changes associated with ageing. Some workers have suggested 
that ageing represents the effects of chance events leading 
to an accumulation of errors in the information coded in DNA 
rather than an inbuilt "Biological clock" which determines 
lifespan (See Chapter l).
Work in this area is particularly difficult since for 
meaningful results to be obtained, large numbers of animals are 
required in each experimental group, and since dietary energy 
restriction itself may influence events, pair-feeding of a control 
group is required. Because of these requirements, much of the 
earlier work is open to criticism and doubt. Thus, the 
assertion by McCayyet al (1939) that dietary energy restriction 
prolongs life was based on a relatively small number of 
survivors from a group of rats many of which had died due to 
factors which these workers considered coincidental. On the other 
hand, the experiment by Comfort et al., (1971) which led them 
to suggest that dietary ethoxyquin increased the life span of 
mice, was not carried out using a pair-feeding protocol and this
leads to uncertainties as to whether differences in food intake 
might have contributed to the observed mortality patterns.
In the work described in this thesis, attempts were made 
to overcome this criticism in that pair-fed controls were used 
throughout, but the logistics were such that only relatively 
small groups could be maintained. It has been obvious that any 
definitive studies on the effects of antioxidants on ageing will 
require larger groups, and a pair-feeding protocol; they will 
inevitably be expensive and require more extensive facilities 
than were available to the Author.
The importance of pair-feeding becomes obvious when one 
considers the long-term effects of 0 .5$ dietary ethoxyquin.
Initially, the impaired palatability of the diet led to 
a reduced food intake and weight gain compared with animals 
fed ad libitum on control diets, but food utilisation was 
unimpaired when compared with pair-fed control animals. At a 
later stage the fall in food intake was accompanied by a fall 
in food utilisation, and was an early indication of the toxic 
effects of ethoxyquin (Rudra et al.,197*0* Clearly, the 
effects of unpalatability and of impaired food utilisation 
would have been impossible to separate without the appropriate 
controls.
In the long term study of antioxidants described in 
Chapter 2 both vitamin E and ethoxyquin at levels of 0.5$ in 
the diet caused a significant reduction in PCV and a significant 
increase in circulating reticulocytes. Ethoxyquin also significantly 
increased the clotting time. Similarly, in the short term study
described in Chapter 6 , the blood of animals receiving diets 
containing 0.05$ vitamin E and 0.5$ ethoxyquin contained significantly 
more reticulocytes than pair-fed controls. The clotting time was 
higher in the antioxidant-treated animals, but the difference only 
reached statistical significance in the case of the animals receiving 
the diet containing 0.5$ vitamin E. The reticulocytosis could be 
due to retarded maturation of red blood cells (March et al.,1969)a 
but it is not clear whether this should be regarded as toxic effect 
of excess vitamin E or the other antioxidant.
The effect of vitamin E on blood clotting time has been observed 
before (March et al«,1973) and in this respect ethoxyquin appears 
to mimic vitamin E. This may suggest that the effects on clotting 
time result from the antioxidant activity, since vitamin E and 
ethoxyquin are structurally unrelated, and may result from effects 
on the oxidation state of the naphthoquinone moiety of vitamin K.
The anti-vitamin K effects of these antioxidants may have some 
therapeutic value. Thus, Corrigan & Marcus (197*0 observed 
that DL-a-tocopheryl acetate had an additional anticoagulant 
activity to that of warfarin and clofibrate in patients receiving 
these anticoagulants. There are obvious implications in respect 
of the vitamin E status of patients receiving anticoagulant 
therapy. Further, it might even be possible that patients 
predispose d to thrombosis and other circulatory disorders might 
benefit from dietary vitamin E supplementation in the absence 
of other anticoagulants. In this context, although the rationale 
behind its use has been uncertain, vitamin E has been claimed 
to be effective in the treatment of intermittent claudication.
Thus a recent well-controlled study by Haeger (197*0 has
demonstrated the efficacy of long-term vitamin E therapy in 
treating this condition. It appears, therefore, that further 
studies into the mechanisms by which vitamin E and ethoxyquin 
influence red blood cell maturation and blood clotting time 
would be warranted. Additionally, it would be of interest to 
investigate the effects of these antioxidants on the membranes 
not only of the haematocytes, but of the cells lining the walls 
of the blood vessels. Such effects may be mediated by direct 
protection against peroxidation in the lipid-rich membrane or, 
indirectly, via effects on polyunsaturated fatty acids and 
prostaglandin synthesis.
In the long term study, the kidney of the etoxyquin-treated 
animals showed evidence of chronic nephritis such as fibrosis 
with heavy infiltration of lymphocytes. The presence of casts 
suggested hyaline degeneration. The changes in the kidney 
differed in character, severity and time, from those frequently 
observed in ageing rats and appeared to be due to the toxic 
effects of ethoxyquin. Chronic exposure to high dose levels of 
ethoxyquin appears necessary to produce these effects as iin 
the short term study, 0 .5$ ethoxyquin in the diet did not elicit 
an obvious nephrotoxic response. No abnormalities were seen 
in the kidneys of animals receiving vitamin E in the diet.
The histology of bones from rats fed a diet containing 
ethoxyquin for 577 days suggested that there had been some inter­
ference with the deposition of calcium. This suggestion is 
supported by the finding that in rats fed 0 .5$ ethoxyquin in 
the diet for two months the humerus contained a significantly
lower concentration of calcium and also weighed less than that 
of the pair-fed controls. Evidence of an effect of ethoxyquin 
on the bone was therefore found before there was a discernible 
effect on the kidneys. The liver of rats given 0.5% 
ethoxyquin in the diet is enlarged and there is proliferation 
of the smooth endoplasmic reticulum (Rahim, 1974). It therefore 
seems possible that an associated increase in activity of the 
mixed function oxidases, causes an increased hydroxylation of 
steroids including vitamin D. It is now well-known that the 
conversion of vitamin D to its active hydroxylated derivative 
takes place in two stages - hydroxylation at the 25 C position 
in the liver, and subsequent hydroxylation at the 1 C position 
in the kidney. Thus, in animals receiving ethoxyquin there is 
possible interference with the production of the active 
metabolite in the liver and kidney. In addition to producing 
25~hydroxycholecalciferol, the liver also converts cholecalciferol 
into polar metabolites that are excreted in the bile. It has 
been postulated, and indeed there is. now evidence to support the 
incrimination of increased activity of drug-metabolising enzymes 
as an etiological factor in the rickets and osteomalacia that 
sometimes occurs as a complication of long term treatment of 
epileptic patients with anticonvulsants (Stamp et al»>1972). 
Furthermore, the long term ingestion of a diet containing 0.5$ 
ethoxyquin results in renal damage which may well reduce the 
activity of the 1-hydroxylase enzyme responsible for the conversion 
of 25-0H cholecalciferol to 1,25 dihydroxy-cholecalciferol.
This aspect of the results needs further investigation in order 
to elucidate the mechanism by which ethoxyquin produces the 
observed effects on kidney and bone, and to determine a no-effect
level. This is necessary since ethoxyquin continues to he used 
as an additive in animal feedstuffs.
Several antioxidants have been reported to prevent carcino­
genesis by known carcinogens including azo dyes (Clayton & Baumann, 
19*19)5 N-2-fluorenyl-acetamide (Ulland et al, 1973), methylcholan- 
threne (Jaffe, 19*+6; Haber & Wissler, 1962) and other polycyclic 
hydrocarbons (Wattenberg, 1972). Ethoxyquin is one of the anti­
oxidants which has been used in such studies. One common feature 
of carcinogenesis is accumulation of malonaldehyde in the tissues 
presumably due to lipid peroxidation. This led Shamberger et al 
(.197*0 s to suggest that this was the key to the common effect 
of structurally unrelated antioxidants in inhibiting carcinogenesis. 
Indeed these workers demonstrated that malonaldehyde is itself 
a carcinogen. While this aspect of the biological effects of vitamin 
E and ethoxyquin was not studied specifically in the work reported 
in this thesis, it was observed that accumulation of lipofuscin 
which is derived from malonaldehyde in the tissues (particularly 
brain) was reduced in animals receiving supplementary antioxidants.
As vitamin E is believed by most workers to exert its 
biological activity because of its antioxidant property i.e. 
by protecting the polyunsaturated fatty acids (PUFA) from autoxidation, 
the effective dose of the vitamin must obviously depend on the amount 
of PUFA in the diet. Harris and Erntree (1963) concluded from 
their studies and those of other workers, that the amount of 
vitamin E needed to prevent deficiency phenomena must depend on 
the quotient vitamin E (mg): PUFA (g) in the diet. In the average 
diet in the U.S.A. in i 960 , the quotient was about 0 .6 . The 
value of the formula is somewhat limited by a number of factors
which might play a role in determining the body’s needs for 
vitamin E. The relationship between vitamin E and PUFA is 
complex as suggested by Alfin-Slater et al., (1969). These 
authors could not find a clear correlation between results of 
the in vitro peroxidative haemolysis tests and plasma tocopherol 
levels. According to a later paper (Alfin-Slater et al.,1972) 
the ratio of vitamin E to linoleate in the diet varied in 
different experimental conditions. In fact, even on a fat- free 
diet, male rats deprived of their essential fatty acid stores 
needed dietary vitamin E. On high linoleate diets a 500 : 1 
ratio of linoleate to vitamin E, was satisfactory, while in 
another experiment a ratio of 2500 : 1 was sufficient. As 
mentioned above, it has been shown (Chapter *+) that the 
supplementation of vitamin E, or the addition of ethoxquin to the 
diet at a level of 0.5$9 reduced the accumulation of lipofuscin 
pigment in rat brain. This matter requires more thorough invest­
igation because of the suggested involvement of the deposition of 
the pigment with changes in brain function during old age. The 
level of antioxidant activity found in the brain as judged by 
the experiments with labelled ethoxyquin (Chapter 5) is however 
low. It may be that this small amount is sufficient to reduce 
the formation of lipofuscin pigment in the brain. Alternatively 
vitamin E and ethoxyquin may regulate entry of the precursor of 
lipofuscin, malonaldehyde (MDA), at the blood brain barrier.
Hassan et al., (1966) noted that most modern formulae for 
feeding babies contain increasing amounts of PUFA which are 
better tolerated and more rapidly absorbed than the old 
formulae. The authors found that infants fed a high PUFA diet
exhibited oedema, skin changes and increased sensitivity to 
peroxide, haemolysis. The changes could be cured by vitamin 
E administration. In Batten's disease a large amount of 
lipopigment accumulates.in the brain cells (Zeman et al., 1970).
The standard treatment for this disorder is a mixture of 
a tocopherol, ascorbic acid, methionine and BHT as suggested 
by Tappel (1972). Clearly, since the requirement for vitamin 
E or other antioxidant varies with diet and in disease conditions 
it is not possible to give a unique statement of the optimum 
dietary intake for vitamin E.
Bieri (1973) reported that ingestion of large doses of 
vitamin E or vitamin C could appreciably reduce an individual’s 
vitamin A status. In view of the evidence that a significant
number of people in the U.S.A. may have low liver reserves of. 
vitamin A, dietary practices that" may exacerbate this problem should
be viewed with concern. Results obtained on rats cannot usually 
be extrapolated directly to man, but food faddists consuming 
excessive amounts of any nutrient should be warned of the dangers 
of nutrient interactions.
The original aim of the project reported in this thesis 
was to study the effects of vitamin E or a synthetic antioxidant, 
ethoxyquin, on some age-related phenomena. Certain aspects of 
age-related change, both at the developmental stage (Chapter 3) 
and in the old animal (Chapter 2), have proved to be amenable 
to manipulation by dietary antioxidants. Specifically, changes 
related to lipid peroxidation which in some theories of ageing 
play a central role, are capable of some limited modification. 
However, the 'apparent advantages must be offset against possible
toxic sequellae which were particularly evident with ethoxyquin, 
although the reticulocytosis produced by a-tocopherol might alone 
suggest that caution should be exercised in recommending very 
large intakes. Many of the questions raised in the course of this 
study remain to be answered by further work both at the biochemical 
level, and by definitive life-span studies in several species.
In the present state of knowledge it is not possible to do more 
than speculate about the mechanisms by which antioxidants may 
modify the whole complex series of events included in the general 
term "Ageing".
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.c administration of ethoxyquin and vitamin E on 
of rats.
. 2 3 4 ■ 5 6 7 8
1
! 9 10 H
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i '
+0.6 +0.8
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EM of determinations of five rats, otherwise the 
in parenthesis.
test and control ad-libiturn group.
es shown * when P < 0.05; ** when P < 0.02; 
when P < 0.002; ***** when P <  0.001, or NS when
c administration of ethoxyquin and vitamin E
(g) of rats.
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Table 6,3. Settings on the Atomic Absorption Spectrophotometer.
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The effect of some antioxidants on lipofuscin accumulation in rat brain.
By D. N. R u d r a , J. W. T. D i c ke rso n and R. W a l k e r, Department of 
Biochemistry, University of Surrey, Guildford GUi $XH, and J. C h a y e n , 
Mathilda and Terence Kennedy Institute of Rheumatology, Hammersmith, 
London W6 yDW
Lipofuscin is formed by autoxidation of polyunsaturated fatty acids and 
accumulates with age, particularly in post-mitotic tissue such as heart (Strehler, 
Mark, Mildan & Gee, 1959; Munnell & Getty, 1968) and brain (Reichel, 
Hollander, Clarke & Strehler, 1968). There is evidence that lipofuscin accumulates 
more rapidly in vitamin E deficiency (Mason, Dam & Granados, 1946) and that 
autoxidation can be retarded by dietary supplementation with vitamin E 
(Weglicki, Reichel & Nair, 1968). Vitamin E-deficient rats showed a greater loss of 
memory function with age than did controls (Lai, Pogacar, Daly & Puri, 1973) and 
the oxidation processes leading to lipofuscin accumulation may play a major role in 
cell ageing and senescence (Strehler & Barrows, 1970). The effects of long-term 
dietary supplementation with a-tocopherol or a synthetic antioxidant, ethoxyquin, 
on lipofuscin accumulation in rat brain have therefore been studied.
Three experimental groups of male Wistar rats were maintained from weaning 
on a commercial powdered diet (Spillers small animal diet) containing 25 g 
antioxidant-free arachis oil/kg and supplemented with (g/kg): 0 5 DL-a-tocopheryl 
acetate, 5 DL-a-tocopheryl acetate and 5 ethoxyquin respectively. Pair-fed control 
groups were maintained concurrently on non-supplemented diets. Animals 
receiving a-tocopheryl acetate were reared for 702 d and those receiving 
ethoxyquin for 557 d. In the latter instance, nephrotoxicity of ethoxyquin led to the 
curtailment of the experiment (Rudra, Dickerson & Walker, 1974). At the end of 
the experimental period the rats were decapitated and the brain was quickly 
removed and cut in half longitudinally. Lipofuscin was assayed on 5 Jim sections 
by fluorescence microscopy and microdensitometry.
Supplementation with antioxidants had no significant effect on the number of 
cells containing lipofuscin, but the amount present as estimated by the intensity of 
fluorescence was significantly lower in all experimental groups than in pair-fed 
controls. The amount of lipofuscin was slightly lower in the brain of animals 
receiving 5 g than those receiving 0 5 g a-tocopheryl acetate/kg.
These results will be discussed in relation to the possible advantages of 
supplementary vitamin E at levels higher than those required to prevent frank 
deficiency in the rat.
We thank Associated Health Foods for financial support.
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Lipid peroxide in the developing rat brain. By R. Walker, D. N. Rudra 
and J. W. T. Dickerson, Department of Biochemistry, University of Surrey, 
Guildford
The pigment ‘lipofuscin’ has been considered to be a normal constituent of nerve 
cells (Greenfield & Meyer, 1963). There is evidence that the amount of lipofuscin 
in human (Strehler, Mark, Mildvan & Gee, 1959) and dog (Munnell & Getty, 
1968) myocardium and in mouse and rat brain (Reichel, Hollander, Clark & Strehler, 
1968) increases with age. It is formed by the autoxidation of polyunsaturated fatty 
acids, and the process can be retarded by dietary supplementation with vitamin E 
(Weglicki, Reichel, & Nair, 1968). However, reports on the changes with age of the 
lipid peroxide content of the rat brain are conflicting, for whereas Pritchard & 
Singh (1961) reported an increase to 15 d of age with a subsequent decrease to a lower 
value at maturity, Yoshikawa & Hirai (1967) reported a steady rise between 1 and 
18 months of age. This subject has been re-examined.
Wistar male rats of known ages between 7 and 189 d were decapitated; the 
brain was quickly removed, dissected into forebrain, cerebellum and brain stem, 
and the parts were weighed and quickly frozen. Lipid peroxide was determined 
in the individual parts of at least five brains at each age from animals of different 
litters by the thiobarbituric acid method (Bieri & Anderson, i960); the results were 
expressed in terms of malondialdehyde (MDA).
In the forebrain and cerebellum the concentration of MDA rose sharply between 
7 and 14 d and fell gradually to a near-mature value by 56 d. The absolute amounts 
in these parts increased rapidly between 7 and 14 d and had reached adult values 
by 21 d. In the brain stem the concentration of MDA fell between 7 and 14 d and 
again between 21 and 28 d. The absolute amounts, however, rose gradually between 
7 and 21 d and fell to a near-mature value by 28 d.
These results were discussed in the light of previous reports.
We thank Associated Health Foods Ltd for financial support.
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Long-term Studies on some Antioxidants in the Rat
! < > < * . %  - t o r o w
D . N . Rudra, J. W. T. Dickerson and R. Walker
Department o f  Biochemistry, University o f Surrey, Guildford GU2 5XH,Surrey, England
O f the antioxidants permitted for use in human foods, ethoxyquin has a limited application in 
apples and pears where the maximum permitted residual level is 3 parts/m illion1 while there 
is no restriction on the use o f tocopherols.
Ethoxyquin at a dietary level of 0.25 to 0.5 % prolonged the lifespan o f mice vvhile vitamin E 
a t similar levels also improved survival rates.-*3 it was not clear whether the prolongevity 
resulted from restriction of food intake since a pair-feeding protocol was not used. We have 
"therefore compared the effects o f vitamin E supplementation and dietary ethoxyquin with 
respect to food intake and body-weight gain over a period of 500 days.
Three groups of five male weanling Wistar rats were given a powdered diet (Spillers) con­
taining, respectively, 0.5 % w/w ethoxyquin, 0.5% or 0.05% w/w DL-a-tocopheryl acetate 
added in antioxidant-free arachis oil (2.5% w/w of the diet). Pair-fed controls for these three 
experimental groups received powdered diet plus 2.5% w/w arachis oil. Another set o f rats 
received the control diet ad libitum. All animals were individually caged and w ater was available 
ad libitum.
Food intake was recorded daily and fresh diet was made up at weekly intervals.
Rats receiving 0.05% a-tocopheryl acetate consistently ate more than controls fed ad lib. 
and body weight was increased relative both to pair-fed and ad lib. controls, reflecting an 
increase in food utilisation. Rats receiving 0.5 % w/w a-tocophcryl acetate ate a similar am ount 
to  controls fed ad lib. and. while some improvement in food utilisation was evident as a higher 
body weight after about 120 days, the effect was never as marked as at the lower level o f 
administration. These results suggest that there may be some advantage in supplementation 
o f animal feedstuff'with vitamin E with regard to food conversion ratio although it is recog­
nised that inter-spccies differences may exist.
Rats receiving 0.5% w/w dietary ethoxyquin initially ate less than controls fed ad lib. and 
hence growth rate w*as depressed, however, since pair-fed controls gained weight a t a similar 
rate, there was no impairment of food utilisation. From the 90th to the 280th days, the food 
intake of the experimental group matched that of controls fed ad lib. but the initial impairment 
o f  body weight was never recovered. After 2S0 days the body weight of the experimental group 
started to fall below that of pair-fed controls and this trend continued. This probably reflects 
a  toxic response since subsequently four animals receiving ethoxyquin died w ith severe kidney 
damage. Kidney damage in rats receiving ethoxyquin at dietary levels in excess of 0.025 % w/w 
has been reported-1 but no such pathology was reported in mice receiving 0.5 % w/w ethoxyquin 
where prolongevity was observed.2 These observations confirm the inter-species difference in 
the toxic response to ethoxyquin and suggest that further work is desirable in evaluating the 
likely hazard to domestic animais and man from the use of ethoxyquin in feedstuff's and food.
. Food Group symposium
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